# EDGAR Filing Document

**Accession Number:** 0001670541
**File Stem:** 0001670541-26-000024
**Filing Date:** 2026-2
**Character Count:** 210125
**Document Hash:** 49d92c136b5905abe844323fb42fbcc1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001670541-26-000024.hdr.sgml**: 20260204

**ACCESSION NUMBER**: 0001670541-26-000024

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 100

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260204

**DATE AS OF CHANGE**: 20260204

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Adient plc
- **CENTRAL INDEX KEY:** 0001670541
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37757
- **FILM NUMBER:** 26598793

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 25 NORTH WALL QUAY
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2
- **BUSINESS PHONE:** 1-734-254-5000

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 25 NORTH WALL QUAY
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Adient Ltd
- **DATE OF NAME CHANGE:** 20160328

?xml version='1.0' encoding='ASCII'? adnt-20251231

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

---

| | |
|:---|:---|
| **FORM** | **10-Q** |

---

☑ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended December 31, 2025

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from __________ to __________

Commission File Number: 001-37757

---

| | |
|:---|:---|
| | ![ADNT.jpg](adnt-20251231_g1.jpg) |
| **Adient plc** | **Adient plc** |
| (exact name of Registrant as specified in its charter) | (exact name of Registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Ireland** | **98-1328821** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer - Identification No.) |
| **25 North Wall Quay, Dublin 1, Ireland D01 H104** | **25 North Wall Quay, Dublin 1, Ireland D01 H104** |
| (Address of principal executive offices) | (Address of principal executive offices) |
| **734-254-5000** | **734-254-5000** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |

---

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |
| **<u>Title of each class</u>** | **<u>Trading symbol</u>** | **<u>Name of exchange on which registered</u>** |
| Ordinary Shares, par value $0.001 | ADNT | New York Stock Exchange |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☑ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). &nbsp;&nbsp;&nbsp;&nbsp;Yes ☐ No ☑

At December 31, 2025, 78,329,803 ordinary shares were outstanding.

------

**Adient plc**

**Form 10-Q**

**For the Three Months Ended December 31, 2025** 

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| <u>[PART I - FINANCIAL INFORMATION](#iab3eb48c9ce044dbbd7e081ef7e9a61b_10)</u> | <u>[PART I - FINANCIAL INFORMATION](#iab3eb48c9ce044dbbd7e081ef7e9a61b_10)</u> | <u>[PART I - FINANCIAL INFORMATION](#iab3eb48c9ce044dbbd7e081ef7e9a61b_10)</u> |
| <u>[Item 1.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_13)</u> | <u>[Unaudited Financial Statements](#iab3eb48c9ce044dbbd7e081ef7e9a61b_13)</u> | <u>[3](#iab3eb48c9ce044dbbd7e081ef7e9a61b_13)</u> |
| <u>[Item 2.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_85)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#iab3eb48c9ce044dbbd7e081ef7e9a61b_85)</u> | <u>[31](#iab3eb48c9ce044dbbd7e081ef7e9a61b_85)</u> |
| <u>[Item 3.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_109)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#iab3eb48c9ce044dbbd7e081ef7e9a61b_109)</u> | <u>[42](#iab3eb48c9ce044dbbd7e081ef7e9a61b_109)</u> |
| <u>[Item 4.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_112)</u> | <u>[Controls and Procedures](#iab3eb48c9ce044dbbd7e081ef7e9a61b_112)</u> | <u>[42](#iab3eb48c9ce044dbbd7e081ef7e9a61b_112)</u> |
| <u>[PART II - OTHER INFORMATION](#iab3eb48c9ce044dbbd7e081ef7e9a61b_115)</u> | <u>[PART II - OTHER INFORMATION](#iab3eb48c9ce044dbbd7e081ef7e9a61b_115)</u> | <u>[PART II - OTHER INFORMATION](#iab3eb48c9ce044dbbd7e081ef7e9a61b_115)</u> |
| <u>[Item 1.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_118)</u>  | <u>[Legal Proceedings](#iab3eb48c9ce044dbbd7e081ef7e9a61b_118)</u> | <u>[44](#iab3eb48c9ce044dbbd7e081ef7e9a61b_118)</u> |
| <u>[Item 1A.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_121)</u> | <u>[Risk Factors](#iab3eb48c9ce044dbbd7e081ef7e9a61b_121)</u> | <u>[44](#iab3eb48c9ce044dbbd7e081ef7e9a61b_121)</u> |
| <u>[Item 2.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_124)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#iab3eb48c9ce044dbbd7e081ef7e9a61b_124)</u> | <u>[44](#iab3eb48c9ce044dbbd7e081ef7e9a61b_124)</u> |
| <u>[Item 3.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_127)</u> | <u>[Defaults Upon Senior Securities](#iab3eb48c9ce044dbbd7e081ef7e9a61b_127)</u> | <u>[45](#iab3eb48c9ce044dbbd7e081ef7e9a61b_127)</u> |
| <u>[Item 4.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_130)</u> | <u>[Mine Safety Disclosures](#iab3eb48c9ce044dbbd7e081ef7e9a61b_130)</u> | <u>[45](#iab3eb48c9ce044dbbd7e081ef7e9a61b_130)</u> |
| <u>[Item 5.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_133)</u> | <u>[Other Information](#iab3eb48c9ce044dbbd7e081ef7e9a61b_133)</u> | <u>[45](#iab3eb48c9ce044dbbd7e081ef7e9a61b_133)</u> |
| <u>[Item 6.](#iab3eb48c9ce044dbbd7e081ef7e9a61b_136)</u> | <u>[Exhibits](#iab3eb48c9ce044dbbd7e081ef7e9a61b_136)</u> | <u>[46](#iab3eb48c9ce044dbbd7e081ef7e9a61b_136)</u> |
|  | <u>[Signatures](#iab3eb48c9ce044dbbd7e081ef7e9a61b_139)</u> | <u>[47](#iab3eb48c9ce044dbbd7e081ef7e9a61b_139)</u> |

---

**Adient plc \| Form 10-Q \| 2**

------

**PART I - FINANCIAL INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Unaudited Financial Statements** |

---

**Adient plc**

**Consolidated Statements of Income (Loss)**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions, except per share data)** | **2025** | **2024** |
| Net sales | $3644 | $3495 |
| Cost of sales | 3427 | 3279 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 217 | 216 |
| Selling, general and administrative expenses | 130 | 125 |
| Restructuring and impairment costs | 24 | 23 |
| Equity income | 27 | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and income taxes | 90 | 93 |
| Net financing charges | 48 | 45 |
| Other pension expense | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 41 | 47 |
| Income tax provision | 42 | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | (1) | 25 |
| Income attributable to noncontrolling interests | 21 | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Adient | $(22) | $— |
| Earnings (loss) per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.28) | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.28) | $— |
| Shares used in computing earnings per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 78.7 | 84.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 78.7 | 84.7 |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 3**

------

**Adient plc**

**Consolidated Statements of Comprehensive Income (Loss)**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Net income (loss) | $(1) | $25 |
| Other comprehensive income, net of tax: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | 14 | (236) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Realized and unrealized gains (losses) on derivatives | 6 | (8) |
| Other comprehensive income (loss) | 20 | (244) |
| Total comprehensive income (loss) | 19 | (219) |
| Comprehensive income attributable to noncontrolling interests | 27 | 6 |
| Comprehensive loss attributable to Adient | $(8) | $(225) |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 4**

------

**Adient plc**

**Consolidated Statements of Financial Position**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| **(in millions, except share and per share data)** | **December 31, 2025** | **September 30, 2025** |
| **Assets** | | |
| Cash and cash equivalents | $855 | $958 |
| Accounts receivable - net | 1638 | 1873 |
| Inventories | 760 | 695 |
| Other current assets | 663 | 607 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current assets | 3916 | 4133 |
| Property, plant and equipment - net | 1401 | 1409 |
| Goodwill | 1812 | 1807 |
| Other intangible assets - net | 313 | 319 |
| Investments in partially-owned affiliates | 312 | 276 |
| Assets held for sale | 12 | 9 |
| Other noncurrent assets | 1008 | 1001 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $8774 | $8954 |
| **Liabilities and Shareholders' Equity** |  |  |
| Short-term debt | $2 | $2 |
| Current portion of long-term debt | 9 | 9 |
| Accounts payable | 2533 | 2549 |
| Accrued compensation and benefits | 317 | 393 |
| Other current liabilities | 731 | 734 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current liabilities | 3592 | 3687 |
| Long-term debt | 2380 | 2386 |
| Pension and postretirement benefits | 112 | 112 |
| Other noncurrent liabilities | 593 | 611 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term liabilities | 3085 | 3109 |
| Commitments and Contingencies (Note 17) |  |  |
| Redeemable noncontrolling interests | 68 | 95 |
| Preferred shares issued, par value $0.001; 100,000,000 shares authorized,<br>Zero shares issued and outstanding at December 31, 2025 |  |  |
| Ordinary shares issued, par value $0.001; $500,000,000 shares authorized, <br>78,329,803 shares issued and outstanding at December 31, 2025 |  |  |
| Additional paid-in capital | 3579 | 3602 |
| Accumulated deficit | (1188) | (1166) |
| Accumulated other comprehensive loss | (656) | (670) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders' equity attributable to Adient | 1735 | 1766 |
| Noncontrolling interests | 294 | 297 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 2029 | 2063 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $8774 | $8954 |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 5**

------

**Adient plc**

**Consolidated Statements of Cash Flows**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| **Operating Activities** |  |  |
| Net loss attributable to Adient | $(22) | $— |
| Income attributable to noncontrolling interests | 21 | 25 |
| Net income (loss) | (1) | 25 |
| Adjustments to reconcile net income to cash provided (used) by operating activities: | Adjustments to reconcile net income to cash provided (used) by operating activities: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 69 | 69 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 11 | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement expense | 3 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement contributions, net |  | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in earnings of partially-owned affiliates, net of dividends received | (27) | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of interests in nonconsolidated partially-owned affiliates |  | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (2) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash impairment charges |  | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity-based compensation | 8 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities excluding impact of acquisitions/divestitures: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables | 243 | 402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (65) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (42) | (70) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | (143) | (329) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued income taxes | 24 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by operating activities | 80 | 109 |
| **Investing Activities** |  |  |
| Capital expenditures | (65) | (64) |
| Sale of property, plant and equipment | 2 | 6 |
| Business divestitures |  | 27 |
| Investments in partially-owned affiliates | (4) | (3) |
| Other | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used by investing activities | (68) | (34) |
| **Financing Activities** |  |  |
| Increase (decrease) in short-term debt |  | (1) |
| Repayment of long-term debt | (2) | (2) |
| Debt financing costs | (6) | (1) |
| Share repurchases | (25) | (25) |
| Acquisition of a noncontrolling interest |  | (28) |
| Dividends paid to and other transactions with noncontrolling interests | (76) | (42) |
| Share based compensation and other | (5) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used by financing activities | (114) | (102) |
| Effect of exchange rate changes on cash and cash equivalents | (1) | (58) |
| **Decrease in cash and cash equivalents** | (103) | (85) |
| Cash and cash equivalents at beginning of period | 958 | 945 |
| Cash and cash equivalents at end of period | $855 | $860 |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 6**

------

**Adient plc**

**Notes to Consolidated Financial Statements**

**(unaudited)**

**1. Organization and Summary of Significant Accounting Policies**

Adient is a global leader in the automotive seating supplier industry and maintains relationships with the largest global automotive original equipment manufacturers, or OEMs. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.

**Basis of Presentation**

The unaudited consolidated financial statements of Adient have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission and in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These interim consolidated financial statements include all adjustments (consisting of normal recurring adjustments) that management believes are necessary for a fair statement of the results of operations, financial position and cash flows of Adient for the interim periods presented. Certain figures for comparative periods were regrouped to conform to current period presentation.

**Principles of Consolidation**

Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient does not have a controlling interest but is assessed to have significant influence on their operations.

*Consolidated VIEs*

Based upon the criteria set forth in the Financial Accounting Standards Board (the "FASB") Accounting Standards Codification ("ASC") 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities ("VIEs") for the reporting periods ended December 31, 2025, and September 30, 2025, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.

The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.

The carrying amounts and classification of assets (none of which are restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

---

| | | |
|:---|:---|:---|
| **(in millions)** | **December 31, 2025** | **September 30, 2025** |
| Current assets | $253 | $304 |
| Noncurrent assets | 95 | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $348 | $398 |
| Current liabilities | $224 | $257 |
| Noncurrent liabilities | 10 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $234 | $267 |

---

**Adient plc \| Form 10-Q \| 7**

------

**Earnings Per Share**

The following table shows the computations of basic and diluted earnings (loss) per share:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions, except per share data)** | **2025** | **2024** |
| **Income available to shareholders** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Adient | $(22) | $— |
| **Weighted average shares outstanding** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Basic weighted average shares outstanding** | 78.7 | 84.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock options, unvested restricted stock and unvested performance share awards |  | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted weight average shares outstanding | 78.7 | 84.7 |
| Earnings (loss) per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.28) | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.28) | $— |

---

Potentially dilutive securities whose effect would have been anti-dilutive are excluded from the computation of diluted earnings per share for the three months ended December 31, 2025 as a result of being in a loss position. The effect of common stock equivalents which would have been anti-dilutive was excluded, and immaterial, from the calculation of diluted earnings per share for the three months ended December 31, 2024.

**New Accounting Pronouncements**

*Standards to be Adopted During Fiscal 2026*

Adient adopted Accounting Standards Codification ("ASU") 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures* in fiscal 2026 which requires additional annual disclosures about the reporting entity's reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes. The ASU also requires further disaggregation of income tax amounts paid by federal, state and foreign, as well as by material jurisdiction.

*Standards Effective After Fiscal 2026*

Adient has considered the new standards that are summarized below, each to be effective after fiscal 2026 which are not expected to significantly impact the consolidated financial statements:

---

| | | |
|:---|:---|:---|
| **Standard to be Adopted** | **Description** | **Date Effective** |
| ASU 2025-05 Measurement of Credit Losses for Accounts<br>Receivable and Contract Assets (Financial Instruments – Credit Losses (Topic 326)) | The ASU provides a practical expedient and an accounting policy election under which conditions at the period-end date can be assumed to remain unchanged for an asset's remaining life when estimating credit losses on current accounts receivable and current contract assets arising from transactions under ASC 606 Revenue from contracts with customers. The update is expected to simplify the credit loss assessment when applying Topic 326. | October 1, 2026 |
| ASU 2024-03 Income Statement - Reporting Comprehensive<br>Income - Expense: Disaggregation Disclosures<br>(Subtopic 220-40) | The ASU requires disclosures of specified information about certain costs and expenses in the notes to financial statements at each interim and annual reporting period, including: the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, and a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. It also requires disclosures of the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. | October 1, 2027 |

---

**Adient plc \| Form 10-Q \| 8**

------

---

| | | |
|:---|:---|:---|
| ASU 2025-06 Intangibles - Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software | The ASU amends the timing for capitalizing eligible internal use software costs. Under the new guidance, an entity is required to start capitalizing software costs when both of the following occur: 1) Management has authorized and committed to funding the software project; and 2) it is probable that the project will be completed and the software will be used to perform the function intended (referred to as the "probable-to-complete recognition threshold"). The ASU does not change the types of costs eligible for capitalization or the associated amortization and impairment guidance. | October 1, 2028 |
| ASU 2025-10 Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities | The ASU provides guidance over recognition, measurement and presentation of government grants received by public business entities. Under the ASU, a government grant is recognized when: 1) it is probable all conditions attached to the grant will be complied and the grant will be received; and 2) specific recognition guidance for the grant related to an asset or income is met. The benefit of the grant is in general recognized in earnings in a systematic and rational manner over the period in which the relevant expenses are recognized. | October 1, 2029 |

---

**2. Revenue Recognition**

Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle, however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer. Approximately 2% of net sales recorded during the first quarter of fiscal 2026 were related to product sales transacted in prior periods.

In pursuit of new program awards, Adient at times agrees to make upfront payments to customers. Each time such a payment is made, Adient evaluates its nature, the underlying economics, legal and compliance ramifications, and other relevant factors and circumstances. These payments are deemed to be consideration payable to customers and are generally recognized as a reduction to revenue once mutually agreed. Certain upfront payments, however, are capitalized as other current and noncurrent assets if they are determined to be incremental, attributable only to the specific new program being awarded, and recoverable. As products under the new program are sold to the customer, the capitalized amount is amortized and recognized as a reduction to revenue over the term of the program, typically between three and seven years. Adient assesses recoverability of the capitalized amounts on an on-going basis. Any amounts that are concluded to be no longer recoverable are immediately recognized as a reduction to revenue. As of December 31, 2025 and September 30, 2025, Adient maintained capitalized upfront payments of $186 million and $174 million, respectively, within other noncurrent assets.

In a typical arrangement with the customer, purchase orders are issued for pre-production activities which consist of engineering, design and development, tooling and prototypes for the manufacture and delivery of component parts. Adient has concluded that these activities are not in the scope of ASC 606, "Revenue from Contracts with Customers."

Adient includes shipping and handling fees billed to customers in revenue, while including costs of shipping and handling in cost of sales. Taxes collected from customers are excluded from revenue and credited directly to obligations to the appropriate government agencies. Payment terms with customers are established based on customary industry and regional practices and do not contain significant financing components.

Contract assets primarily relate to the right to consideration for work completed, but not billed at the reporting date on contracts with customers. The contract assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet

**Adient plc \| Form 10-Q \| 9**

------

been satisfied and revenue has not been recognized. No material contract assets or liabilities exist at December 31, 2025 or at September 30, 2025. As described above, the issuance of a purchase order and/or a materials release by the customer represents the point at which an enforceable contract with the customer exists. Therefore, Adient has elected to apply the practical expedient in ASC 606 and does not disclose information about the remaining performance obligations that have an original expected duration of one year or less. Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for disaggregated revenue by geographical market.

**3. Acquisitions and Divestitures**

During the first quarter of fiscal 2026, Adient invested $4 million to acquire 49% interest in a joint venture in China. The investment is expected to expand Adient's commercial and geographical footprint in China. The new investment is accounted for using the equity method of accounting and presented as part of investments in partially-owned affiliates on Adient's consolidated statements of financial position.

During the first quarter of fiscal 2025, Adient acquired all of the noncontrolling interest in Technotrim, Inc. ("Technotrim") for a value of $28 million and sold all of its partially-owned interests in Setex, Inc. and Setex SRL (together as "Setex") for a value of $27 million. The sale of Setex resulted in a one-time gain on sale of $4 million. The acquisition of all noncontrolling interest in Technotrim was recorded to equity. The transactions are expected to provide additional synergies through optimization of Adient's manufacturing footprint and additional control over its manufacturing presence in the Americas.

**4. Inventories**

Inventories consisted of the following:

---

| | | |
|:---|:---|:---|
| **(in millions)** | **December 31, 2025** | **September 30, 2025** |
| Raw materials and supplies | $565 | $522 |
| Work-in-process | 28 | 29 |
| Finished goods | 167 | 144 |
| Inventories | $760 | $695 |

---

**5. Goodwill and Other Intangible Assets**

The changes in the carrying amount of goodwill are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in millions)** | **Americas** | **EMEA** | **Asia** | **Total** |
| Balance at September 30, 2025 | $607 | $— | $1200 | $1807 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currency translation | (1) |  | 6 | 5 |
| Balance at December 31, 2025 | $606 | $— | $1206 | $1812 |

---

Due to the continued and sustained decline in the market value of its ordinary shares during the second quarter of fiscal 2025 resulting from the uncertainties surrounding future production volume within the automotive industry, a triggering event was identified requiring a quantitative impairment analysis as of March 31, 2025. As a result, a $333 million non-cash goodwill impairment was recorded in the EMEA reporting unit during the quarter ended March 31, 2025. No amounts of goodwill remain recorded in EMEA.

Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for more information on Adient's reportable segments.

**Adient plc \| Form 10-Q \| 10**

------

Adient's other intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>**(in millions)** | **Gross<br>Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net** | **Gross<br>Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net** |
| Other intangible assets |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patented technology | $82 | $(48) | $34 | $81 | $(45) | $36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer relationships | 547 | (279) | 268 | 537 | (265) | 272 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 15 | (4) | 11 | 15 | (4) | 11 |
| Total other intangible assets | $644 | $(331) | $313 | $633 | $(314) | $319 |

---

Amortization of other intangible assets for the three months ended December 31, 2025 and 2024 was $11 million and $11 million, respectively.

**6. Product Warranties**

Adient offers warranties to its customers depending upon the specific product and terms of the customer purchase agreement. A typical warranty program requires that Adient replace defective products within a specified time period from the date of sale. Adient records an estimate for future warranty-related costs based on actual historical return rates and other known factors. Based on analysis of return rates and other factors, Adient's warranty provisions are adjusted as necessary. Adient monitors its warranty activity and adjusts its reserve estimates when it is probable that future warranty costs will be different than those estimates. Adient's product warranty liability is recorded in the consolidated statements of financial position in other current liabilities.

The changes in Adient's total product warranty liability are as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**December 31,** | **Three Months Ended**<br>**December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Balance at beginning of period | $22 | $22 |
| Accruals for warranties issued during the period |  |  |
| Settlements/adjustments made (in cash or in kind) during the period | (1) | (1) |
| Balance at end of period | $21 | $21 |

---

**7. Leases**

Adient's lease portfolio consists of operating leases for real estate including production facilities, warehouses and administrative offices, equipment such as forklifts and computer servers and laptops, and fleet vehicles.

The components of lease costs included in the consolidated statements of income (loss) for the three months ended December 31, 2025 and 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Operating lease cost | $28 | $27 |
| Short-term lease cost | 8 | 7 |
| Total lease cost | $36 | $34 |

---

**Adient plc \| Form 10-Q \| 11**

------

Operating lease right-of-use assets and lease liabilities included in the consolidated statements of financial position were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | | **December 31, 2025** | **September 30, 2025** |
| **Operating leases:** | | | |
| Operating lease right-of-use assets | Other noncurrent assets | $258 | $259 |
| Operating lease liabilities - current | Other current liabilities | $82 | $82 |
| Operating lease liabilities - noncurrent | Other noncurrent liabilities | 175 | 176 |
|  |  | $257 | $258 |
| **Weighted average remaining lease term:** |  |  |  |
| Operating leases |  | 5 years | 5 years |
| **Weighted average discount rate:** |  |  |  |
| Operating leases |  | 6.4% | 6.0% |

---

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of December 31, 2025 were as follows:

---

| | |
|:---|:---|
| **Fiscal years (in millions)** | **Operating Leases** |
| 2026 (excluding the three months ended December 31, 2025) | $75 |
| 2027 | 76 |
| 2028 | 52 |
| 2029 | 33 |
| 2030 | 22 |
| Thereafter | 46 |
| Total lease payments | 304 |
| Less: imputed interest | (47) |
| Present value of lease liabilities | $257 |

---

Supplemental cash flow information related to leases was as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Right-of-use assets obtained in exchange for lease obligations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases (non-cash activity) | $18 | $19 |
| Operating cash flows: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for amounts included in the measurement of lease liabilities | $28 | $27 |

---

**Adient plc \| Form 10-Q \| 12**

------

**8. Debt and Financing Arrangements**

Long-term and short-term debt consisted of the following:

---

| | | |
|:---|:---|:---|
| **(in millions)** | **December 31, 2025** | **September 30, 2025** |
| *Long-term debt:* |  |  |
| 8.25% Notes due 2031 | $500 | $500 |
| 7.00% Secured Notes due 2028 | 500 | 500 |
| Term Loan B due in 2031 | 624 | 626 |
| 7.50% Notes due in 2033 | 795 | 795 |
| Other bank borrowings and finance lease obligations | 6 | 5 |
| Less: debt issuance costs | (36) | (31) |
| Gross long-term debt | 2389 | 2395 |
| Less: current portion | 9 | 9 |
| Net long-term debt | $2380 | $2386 |
| *Short-term debt:* |  |  |
| Other bank borrowings | $2 | $2 |
| Total short-term debt | $2 | $2 |

---

As of September 30, 2025, Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintained an asset-based revolving credit facility (the "ABL Credit Facility"), which provided for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. During the first quarter of fiscal 2026, Adient amended the ABL Credit Facility, reducing the maximum facility from $1,250 million to $1,000 million (consisting of a North American subfacility of up to $895 million and a European subfacility of up to $105 million). Under the amended agreement, Adient will pay a commitment fee of 0.20% - 0.25% (previously 0.25% to 0.375%) on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Adient incurred $6 million of costs associated with this amendment, which was recorded as deferred financing costs. The amended ABL Credit Facility is set to mature in October 2030 (previously November 2027), subject to certain springing maturity provisions. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the amended ABL Credit Facility then in effect. Subject to certain conditions, the amended ABL Credit Facility may be expanded by up to $500 million in additional commitments. Loans under the amended ABL Credit Facility may be denominated, at the option of Adient, in U.S. Dollars, Euros, Pounds Sterling or Swedish Krona. It also provides flexibility for future amendments to the amended ABL Credit Facility to incorporate certain sustainability-based pricing provisions. The amended ABL Credit Facility is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. Interest is payable on the amended ABL Credit Facility at a fluctuating rate of interest determined by reference to Term SOFR, in the case of amounts outstanding in Dollars, EURIBOR, in the case of amounts outstanding in Euros, STIBOR, in the case of amounts outstanding in Swedish Krona and SONIA, in the case of amounts outstanding in Pounds Sterling, in each case, plus an applicable margin of 1.25% - 1.75% (previously 1.50% to 2.00%). As of December 31, 2025, Adient had not drawn down on the amended ABL Credit Facility and had availability under this facility of $823 million (net of $8 million of letters of credit).

In addition, Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintains a senior secured term loan facility (the "Term Loan B Agreement"), that had an outstanding balance of $624 million and $626 million as of December 31, 2025 and September 30, 2025, respectively. During the first quarter of fiscal 2025, the Term Loan B Agreement was amended to reduce the applicable margin from 2.75% to 2.25%. Adient incurred $1 million of costs associated with the modification, which was recorded as deferred financing costs. The maturity date was also extended from April 2028 to January 2031. The amended Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance due at final maturity. The amended Term Loan B Agreement permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject

**Adient plc \| Form 10-Q \| 13**

------

to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. Interest on the amended Term Loan B Agreement accrues at Term SOFR plus an applicable margin. During the second quarter of fiscal 2026, Adient further amended the Term Loan B Agreement to reduce the applicable margin from 2.25% to 2.00%. Adient incurred $1 million of costs associated with this amendment, which was recorded as deferred financing costs.

The amended ABL Credit Facility and amended Term Loan B Agreement contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient's capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient's and its restricted subsidiaries' assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains (i) $500 million in aggregate principal amount of 7.00% senior secured notes due 2028, (ii) $500 million in aggregate principal amount of 8.250% senior unsecured notes due 2031 and (iii) $795 million in aggregate principal amount of 7.50% senior unsecured notes due 2033. Interest on notes (i) and (ii) are paid on April 15 and October 15 each year. Interest on note (iii) is paid on February 15 and August 15 each year. These notes contain covenants that are usual and customary.

**Net Financing Charges**

Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Interest expense, net of capitalized interest costs | $52 | $47 |
| Banking fees and debt issuance cost amortization | 4 | 4 |
| Interest income | (8) | (7) |
| Net foreign exchange |  | 1 |
| Net financing charges | $48 | $45 |

---

Total interest paid on both short and long-term debt for the three months ended December 31, 2025 and 2024 was $53 million and $52 million, respectively.

**Other Arrangements**

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of December 31, 2025, $169 million was funded under these programs compared to $185 million as of September 30, 2025.

Adient also has a program with an external financial institution under which Adient's suppliers can sell their receivables from Adient to the financial institution at their sole discretion. Adient is not a party to the agreements between the participating suppliers and the financial institution. Adient's obligation under the program is to pay the original amounts of supplier invoices to the financial institution on the original invoice dates. No fees are paid and no assets are pledged by Adient. The payment terms for trade payables can range from 45 days to 120 days depending on types of services and goods being purchased. The payment terms for molds, dies and other tools that are acquired as part of pre-production activities are in general longer, and are normally dependent on the terms which Adient has agreed with its customers. As of December 31, 2025, Adient's liabilities related to this program were $109 million which is recorded within accounts payable ($14 million) and other current liabilities ($95 million) in Adient's consolidated statements of financial position. As of September 30, 2025, Adient's liabilities related to this program were $105 million which is recorded within accounts payable ($16 million) and other current liabilities

**Adient plc \| Form 10-Q \| 14**

------

($89 million) in Adient's consolidated statements of financial position. Cash flows related to the program are all presented within operating activities in Adient's consolidated statements of cash flows.

**9. Derivative Instruments and Hedging Activities**

Adient selectively uses derivative instruments to reduce Adient's market risk associated with changes in foreign currency. Under Adient's policy, the use of derivatives is restricted to those intended for hedging purposes; the use of any derivative instrument for speculative purposes is strictly prohibited. A description of each type of derivative utilized to manage Adient's risk is included in the following paragraphs. In addition, refer to Note 10, "Fair Value Measurements," of the notes to the consolidated financial statements for information related to the fair value measurements and valuation methods utilized by Adient for each derivative type.

Adient has global operations and participates in the foreign exchange markets to minimize its risk of loss from fluctuations in foreign currency exchange rates. Adient primarily uses foreign currency exchange contracts to hedge certain foreign exchange rate exposures. Adient hedges 70% to 90% of the nominal amount of each of its known foreign exchange transactional exposures. Gains and losses on derivative contracts offset gains and losses on underlying foreign currency exposures. These contracts have been designated as cash flow hedges under ASC 815, "Derivatives and Hedging," and the hedge gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. All contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at December 31, 2025 and September 30, 2025, respectively.

Adient also utilizes foreign currency exchange contracts and cross currency interest rate swap contracts to selectively hedge portions of its investments in foreign subsidiaries. Such contracts are designated as net investment hedges, with the objective of managing the impact of foreign currency exchange rate fluctuations on Adient's net investments. The currency effects of such contracts are reflected in the AOCI account within shareholders' equity attributable to Adient, where gains and losses recorded on Adient's net investment are offset.

During the first quarter of fiscal 2026, Adient entered into a cross-currency interest rate swap agreement with an aggregate notional amount of $60 million in order to hedge the foreign currency risk associated with its net investment in Japanese subsidiaries. The agreement will expire during the first quarter of fiscal 2027 and has been designated as a net investment hedge of Adient's Japanese yen denominated subsidiaries. The currency remeasurement impacts of the instruments are reflected in the AOCI account within shareholders' equity attributable to Adient where they offset gains and losses recorded on Adient's net investment. Under the terms of the agreement, Adient receives fixed-rate interest payments in U.S. dollar at a rate of 2.85% and pays 0.00% on the fixed-rate yen leg. The interest rate differentials are recorded within net financing charges on the consolidated statement of income (loss).

During the fourth quarter of fiscal 2025, Adient entered into cross-currency interest rate swap agreements with an aggregate notional amount of $325 million in order to hedge the foreign currency risk associated with its net investment in European subsidiaries. These agreements expire over a three-year period and have been designated as net investment hedges of Adient's Euro denominated subsidiaries. Under the terms of the agreements, Adient receives fixed-rate interest payments in U.S. dollar at a weighted average rate of 1.85% and pays 0.00% on the fixed-rate Euro leg. The interest rate differentials are recorded within net financing charges on the consolidated statement of income (loss).

During the third quarter of fiscal 2025, Adient entered into a ¥559 million ($78 million) foreign currency exchange contract to selectively hedge portions of its net investment in China. The contract is set to mature in October 2026.

During the third quarter of fiscal 2024, Adient entered into a ¥570 million ($78 million) foreign currency exchange contract to selectively hedge portions of its net investment in China. During the first quarter of fiscal 2026, ¥413 million ($58 million) of the notional amount have matured, the impact of which was not material. The remainder of the contract is set to mature in June 2026.

During the second quarter of fiscal 2024, Adient entered into a ¥685 million ($96 million) foreign exchange forward contract to selectively hedge portions of its net investment in China. The contract matured during the first quarter of fiscal 2025, the impact of which was not material.

**Adient plc \| Form 10-Q \| 15**

------

The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Derivatives and Hedging<br>Activities Designated as<br>Hedging Instruments<br>under ASC 815** | **Derivatives and Hedging<br>Activities Designated as<br>Hedging Instruments<br>under ASC 815** | **Derivatives and Hedging<br>Activities Not Designated as<br>Hedging Instruments<br>under ASC 815** | **Derivatives and Hedging<br>Activities Not Designated as<br>Hedging Instruments<br>under ASC 815** |
| <br>**(in millions)** | **December 31, 2025** | **September 30, 2025** | **December 31, 2025** | **September 30, 2025** |
| Other current assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $34 | $32 | $7 | $4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 1 |  |  |  |
| Other noncurrent assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 2 | 1 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $37 | $33 | $7 | $4 |
| Other current liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $6 | $7 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps |  | 1 |  |  |
| Other noncurrent liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives |  | 2 |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 3 | 3 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $9 | $13 | $— | $1 |

---

Adient enters into International Swaps and Derivatives Associations ("ISDA") master netting agreements with counterparties that permit the net settlement of amounts owed under the derivative contracts. The master netting agreements generally provide for net settlement of all outstanding contracts with a counterparty in the case of an event of default or a termination event. Adient has not elected to offset the fair value positions of the derivative contracts recorded in the consolidated statements of financial position. Collateral is generally not required of Adient or the counterparties under the master netting agreements. As of December 31, 2025 and September 30, 2025, no cash collateral was received or pledged under the master netting agreements.

The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Assets** | **Assets** | **Liabilities** | **Liabilities** |
|<br>**(in millions)** | **December 31, 2025** | **September 30, 2025** | **December 31, 2025** | **September 30, 2025** |
| Gross amount recognized | $44 | $37 | $9 | $14 |
| Gross amount eligible for offsetting | (9) | (10) | (9) | (10) |
| Net amount | $35 | $27 | $— | $4 |

---

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
| **(in millions)** | **2025** | **2024** |
| Foreign currency exchange derivatives | $20 | $(14) |

---

**Adient plc \| Form 10-Q \| 16**

------

The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income (loss):

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
| **(in millions)** | | **2025** | **2024** |
| Foreign currency exchange derivatives | Cost of sales | $12 | $(8) |

---

During the next twelve months, $30 million of pretax gain on cash flow hedges are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).

The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
| **(in millions)** | | **2025** | **2024** |
| Foreign currency exchange derivatives | Cost of sales | $— | $(3) |
| Foreign currency exchange derivatives | Net financing charges | 4 | (13) |
| Total |  | $4 | $(16) |

---

The effective portion of pretax gains (losses) recorded in currency translation adjustment ("CTA") within other comprehensive income (loss) related to net investment hedges was $0 million and $4 million for the three months ended December 31, 2025 and 2024, respectively. For the three months ended December 31, 2025 and 2024, respectively, no significant gains or losses were reclassified from CTA into income for Adient's outstanding net investment hedges.

For the three months ended December 31, 2025 and 2024, no ineffectiveness was recognized in the consolidated statements of income (loss) resulting from cash flow hedges.

**10. Fair Value Measurements**

ASC 820, "Fair Value Measurement," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows:

*Level 1:* Observable inputs such as quoted prices in active markets;

*Level 2:* Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

*Level 3:* Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions.

ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.

**Recurring Fair Value Measurements**

The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

**Adient plc \| Form 10-Q \| 17**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** |
|<br>**(in millions)** | **Total as of** <br>**December 31, 2025** | **Quoted Prices<br>in Active<br>Markets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** |
| Other current assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $41 | $— | $41 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 1 |  | 1 |  |
| Other noncurrent assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 2 |  | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $44 | $— | $44 | $— |
| Other current liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $6 |  | $6 |  |
| Other noncurrent liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 3 |  | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $9 | $— | $9 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** |
|<br>**(in millions)** | **Total as of**<br>**September 30, 2025** | **Quoted Prices<br>in Active<br>Markets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** |
| Other current assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $36 | $— | $36 | $— |
| Other noncurrent assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 1 |  | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $37 | $— | $37 | $— |
| Other current liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $7 | $— | $7 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 1 |  | 1 |  |
| Other noncurrent liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 3 |  | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 3 |  | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $14 | $— | $14 | $— |

---

**Valuation Methods**

*Foreign currency exchange derivatives:* Adient selectively hedges anticipated transactions and net investments that are subject to foreign exchange rate risk primarily using foreign currency exchange hedge contracts. The foreign currency exchange derivatives are valued under a market approach using publicized spot and forward prices. Changes in fair value on foreign exchange derivatives accounted for as hedging instruments under ASC 815 are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. These contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at December 31, 2025 and September 30, 2025, respectively. The changes in fair value of foreign currency exchange derivatives not designated as hedging instruments under ASC 815 are recorded in the consolidated statements of income (loss).

The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The fair value of long-term debt, which was $2.5 billion at both December 31, 2025 and September 30, 2025, was determined primarily using market quotes classified as Level 1 inputs within the ASC 820 fair value hierarchy.

**Adient plc \| Form 10-Q \| 18**

------

**11. Equity and Noncontrolling Interests**

For the three months ended December 31, 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Ordinary Shares** | **Additional Paid-in Capital** | **Retained Earnings<br>(Accumulated Deficit)** | **Accumulated Other Comprehensive Income (Loss)** | **Shareholders' Equity Attributable<br> to Adient** | **Shareholders' Equity Attributable to Noncontrolling Interests** | **Total Equity** |
| **Balance at September 30, 2025** | $**—** | $**3602** | $**(1166)** | $**(670)** | $**1766** | $**297** | $**2063** |
| Net income (loss) |  |  | (22) |  | **(22)** | 12 | **(10)** |
| Foreign currency translation adjustments |  |  |  | 8 | **8** | 3 | **11** |
| Realized and unrealized gains on derivatives |  |  |  | 6 | **6** |  | **6** |
| Dividends attributable to noncontrolling interests |  |  |  |  | **—** | (18) | **(18)** |
| Repurchases of common stock |  | (25) |  |  | **(25)** |  | **(25)** |
| Share based compensation and other |  | 2 |  |  | **2** |  | **2** |
| **Balance at December 31, 2025** | $**—** | $**3579** | $**(1188)** | $**(656)** | $**1735** | $**294** | $**2029** |

---

For the three months ended December 31, 2024:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Ordinary Shares** | **Additional Paid-in Capital** | **Retained Earnings<br>(Accumulated Deficit)** | **Accumulated Other Comprehensive Income (Loss)** | **Shareholders' Equity Attributable<br> to Adient** | **Shareholders' Equity Attributable to Noncontrolling Interests** | **Total Equity** |
| **Balance at September 30, 2024** | $**—** | $**3712** | $**(885)** | $**(693)** | $**2134** | $**309** | $**2443** |
| Net income |  |  |  |  | **—** | 15 | **15** |
| Foreign currency translation adjustments |  |  |  | (217) | **(217)** | (11) | **(228)** |
| Realized and unrealized gains (losses) on derivatives |  |  |  | (8) | **(8)** |  | **(8)** |
| Dividends attributable to noncontrolling interests |  |  |  |  | **—** | (10) | **(10)** |
| Purchase of noncontrolling interest <sup>(1)</sup> |  | (7) |  | (2) | **(9)** | (19) | **(28)** |
| Repurchases of common stock |  | (25) |  |  | **(25)** |  | **(25)** |
| Share based compensation and other |  | 2 |  |  | **2** |  | **2** |
| **Balance at December 31, 2024** | $**—** | $**3682** | $**(885)** | $**(920)** | $**1877** | $**284** | $**2161** |

---

<sup>(1)</sup> Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.

**Adient plc \| Form 10-Q \| 19**

------

The following table presents changes in AOCI attributable to Adient:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| **Foreign currency translation adjustments** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | $(687) | $(673) |
| &nbsp;&nbsp;&nbsp;&nbsp;Aggregate adjustment for the period, net of tax | 8 | (219) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period <sup>(1)</sup> | $(679) | $(892) |
| **Realized and unrealized gains (losses) on derivatives** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | $18 | $(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Current period changes in fair value, net of tax | 16 | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification to income, net of tax | (10) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | $24 | $(27) |
| **Pension and postretirement plans** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | $(1) | $(1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | $(1) | $(1) |
| Accumulated other comprehensive loss, end of period | $(656) | $(920) |

---

<sup>(1)</sup> Foreign currency translation adjustments as of December 31, 2025 and 2024 include (losses) gains on designated net investment hedge instruments of $(7) million and $1 million, respectively. During the next twelve months, no gains or losses are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).

Adient consolidates certain subsidiaries in which the noncontrolling interest party has within their control the right to require Adient to redeem all or a portion of its interest in the subsidiary. These redeemable noncontrolling interests are reported at their estimated redemption value. Any adjustment to the redemption value impacts retained earnings but does not impact net income. Redeemable noncontrolling interests which are redeemable only upon future events, the occurrence of which is not currently probable, are recorded at carrying value. The following table presents changes in the redeemable noncontrolling interests:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Beginning balance | $95 | $91 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | 9 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends | (39) | (31) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | 3 | (8) |
| Ending balance | $68 | $62 |

---

**Repurchases of Equity Securities**

In November 2022, Adient's board of directors authorized the repurchase of Adient's ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient's ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. From fiscal 2023 through fiscal 2025, Adient repurchased and immediately retired a total of 17,297,377 ordinary shares. The aggregate amount of cash paid to repurchase the shares was $465 million, all of which had been spent through September 30, 2025. During the first quarter of fiscal 2026, Adient repurchased and immediately retired 1,232,932 of its ordinary shares at an average purchase price per share of $20.27, for an aggregate amount of cash paid of $25 million. As of December 31, 2025, the remaining aggregate amount of authorization remaining under the share repurchase authorization was $110 million.

**Adient plc \| Form 10-Q \| 20**

------

**12. Retirement Plans**

Adient maintains non-contributory defined benefit pension plans covering primarily non-U.S. employees and a limited number of U.S. employees. The following table contains the components of net periodic benefit cost:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Service cost | $2 | $1 |
| Interest cost | 4 | 4 |
| Expected return on plan assets | (3) | (3) |
| Net periodic benefit cost | $3 | $2 |

---

The interest cost, expected return on plan assets, and net actuarial and settlement/curtailment (gain) loss components of net periodic benefit cost are included in other pension expense in the consolidated statements of income (loss).

**13. Restructuring and Impairment Costs**

*Restructuring*

To better align its resources with its overall strategies and reduce the cost structure of its global operations to address the softness in certain underlying markets, Adient commits to restructuring plans as necessary. Adient, in general, records costs associated with separation programs when management has approved the plan for separation, the affected employees are identified, and it is unlikely that actions required to complete the separation plan will change significantly. Costs associated with benefits that are contingent on the employee continuing to provide service are accrued over the required service period. All other costs associated with restructuring activities are expensed as incurred.

During the first three months of fiscal 2026, Adient committed to restructuring actions ("2026 Plan") resulting in charges of $23 million. Additional charges totaling $1 million related to prior year plans were also recorded during the three months ended December 31, 2025. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA. The 2026 Plan is being implemented in response to manufacturing footprint and structural changes occurring in the global automotive industry and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with the 2026 Plan will primarily occur in fiscal years 2026 and 2027, and are expected to be substantially complete by fiscal year 2027. Restructuring costs are included in restructuring and impairment costs in the consolidated statements of income (loss). The following tables summarize the changes in Adient's restructuring reserve.

**Adient plc \| Form 10-Q \| 21**

------

For the three months ended December 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | **Employee Severance and Termination Benefits** | **Currency<br>Translation** | **Total** |
| Balance at September 30, 2025 | $128 | $6 | $134 |
| &nbsp;&nbsp;&nbsp;2026 Plan charges | 23 |  | 23 |
| &nbsp;&nbsp;&nbsp;Utilized - cash | (16) |  | (16) |
| &nbsp;&nbsp;&nbsp;Noncash and other adjustments | 1 |  | 1 |
| Balance at December 31, 2025 | $136 | $6 | $142 |
| Current restructuring reserve - other current liabilities |  |  | $93 |
| Noncurrent restructuring reserve - other noncurrent liabilities |  |  | 49 |
| Balance at December 31, 2025 |  |  | $142 |

---

During the first three months of fiscal 2025, Adient committed to restructuring actions ("2025 Plan") resulting in charges of $9 million. Additional charges totaling $4 million related to prior year plans were also recorded during the three months ended December 31, 2024. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in Asia and EMEA. The 2025 Plan is being implemented in response to manufacturing footprint and structural changes occurring in the global automotive industry and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with these specific plans primarily occur in fiscal years 2025 and 2026 and are expected to be substantially complete by fiscal year 2027. Restructuring costs are included in restructuring and impairment costs in the consolidated statements of income. The following tables summarize the changes in Adient's restructuring reserve.

For the three months ended December 31, 2024:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | **Employee Severance and Termination Benefits** | **Currency<br>Translation** | **Total** |
| Balance at September 30, 2024 | $181 | $1 | $182 |
| &nbsp;&nbsp;&nbsp;2025 Plan charges | 9 |  | 9 |
| &nbsp;&nbsp;&nbsp;Utilized - cash | (29) |  | (29) |
| &nbsp;&nbsp;&nbsp;Noncash and other adjustments | 4 | (12) | (8) |
| Balance at December 31, 2024 | $165 | $(11) | $154 |
| Current restructuring reserve - other current liabilities |  |  | $100 |
| Noncurrent restructuring reserve - other noncurrent liabilities |  |  | 54 |
| Balance at December 31, 2024 |  |  | $154 |

---

*Impairment*

During the first three months of fiscal 2025, Adient recorded a non-cash impairment loss of $10 million on its investment in Adient Aerospace. The impairment is included in restructuring and impairment costs in the consolidated statements of income (loss). Refer also to Note 5, "Goodwill and Other Intangible Assets" of the notes to the consolidated financial statements for information about the EMEA goodwill impairment recorded during fiscal 2025.

**Adient plc \| Form 10-Q \| 22**

------

**14. Income Taxes**

In calculating the provision for income taxes, Adient uses an estimate of the annual effective tax rate based upon the facts and circumstances known at each interim period. On a quarterly basis, the actual effective tax rate is adjusted, as appropriate, based on changes in facts and circumstances, if any, as compared to those forecasted at the beginning of the fiscal year and each interim period thereafter. For the three months ended December 31, 2025, Adient's income tax expense was $42 million equating to an effective tax rate of 102%. The three month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the establishment of uncertain tax positions associated with a foreign tax audit settlement expected to be finalized in fiscal 2026 and the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by tax benefits related to audit closures and statute expirations. For the three months ended December 31, 2024, Adient's income tax expense was $22 million equating to an effective tax rate of 47%. The three month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances and tax expense related to foreign exchange remeasurements of tax balances primarily in Mexico, partially offset by tax benefits from the release of uncertain tax positions due to statute expirations.

**Valuation Allowances**

As a result of Adient's first quarter fiscal 2026 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined that no changes to valuation allowances were required.

Adient reviews the realizability of its deferred tax assets on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or combined group recording the net deferred tax asset are considered, along with any other positive or negative evidence. All of the factors that Adient considers in evaluating whether and when to establish or release all or a portion of the deferred tax asset valuation allowance involve significant judgment. Since future financial results may differ from previous estimates, periodic adjustments to Adient's valuation allowances may be necessary.

Given current earnings and anticipated future earnings at certain subsidiaries, Adient believes that there is a reasonable possibility that sufficient positive evidence may become available that would allow the release of all, or a portion of, valuation allowances at certain subsidiaries within the next twelve months. A release of valuation allowances, if any, would result in the recognition of certain deferred tax assets which could generate a material income tax benefit for the period in which such release is recorded.

**Uncertain Tax Positions**

At December 31, 2025, Adient had gross tax effected unrecognized tax benefits of $405 million. If recognized, $127 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at December 31, 2025 was approximately $33 million (net of tax benefit). The interest and penalties accrued for the three months ended December 31, 2025 was $14 million, which includes $12 million of interest and penalties on uncertain tax positions related to a foreign tax audit settlement that was initiated in the first quarter of fiscal 2026. As a result of initiating the foreign tax audit settlement, Adient also recognized tax expense (excluding interest and penalties) of $10 million during the three months ended December 31, 2025. Subsequent to December 31, 2025, there was a partial settlement of this foreign tax audit, with final settlement expected during the second quarter of fiscal 2026. The final settlement is not expected to result in a material change to amounts recorded at December 31, 2025. Additionally, during the three months ended December 31, 2025, Adient recognized a tax benefit of $10 million due to the release of uncertain tax positions due to audit closures and statute expirations. At September 30, 2025, Adient had gross tax effected unrecognized tax benefits of $404 million. If recognized, $114 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at September 30, 2025 was approximately $21 million (net of tax benefit). The interest and penalties accrued for the three months ended December 31, 2024 was $1 million. Adient recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.

**Adient plc \| Form 10-Q \| 23**

------

**Other**

The Organization for Economic Cooperation and Development's Pillar Two initiative, which introduced a 15% global minimum tax applied on a country by country basis, was applicable for Adient beginning in fiscal 2025. Adient has estimated the annual effect of these rules and the impact on Adient's effective tax rate is not material. Adient will continue to monitor and evaluate new legislation and guidance related to Pillar Two, including the OECD's administrative guidance published on January 5, 2026, which could change our current assessment.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense limitation. ASC 740 requires the effects of changes in tax rates and laws to be recognized in the period in which the legislation is enacted. The OBBBA did not have a material impact on Adient's consolidated financial statements. Adient will continue to evaluate the OBBBA and related guidance.

**15. Segment Information**

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East, and Africa ("EMEA"); and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring-related costs, net mark-to-market adjustments on pension plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

The President and Chief Executive Officer is Adient's chief operating decision maker ("CODM"). The CODM evaluates the performance of the reportable segments using Adjusted EBITDA. Adjusted EBITDA is used for forecasting and to measure periodic performance and cash flow generation of the reportable segments and to make capital allocation decisions within the operations that ultimately provide shareholder returns.

The following tables summarize Adient's reportable segments' sales and Adjusted EBITDA for the three months ended December 31, 2025 and 2024, respectively, which include significant expenses that align with the segment-level information that is regularly provided to the CODM. The reportable segments' Adjusted EBITDA is reconciled to income (loss) before income taxes respectively.

**Adient plc \| Form 10-Q \| 24**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**December 31, 2025** | **Three Months Ended**<br>**December 31, 2025** | **Three Months Ended**<br>**December 31, 2025** | **Three Months Ended**<br>**December 31, 2025** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Consolidated** |
| Segment net sales | $1642 | $1205 | $819 | $3666 |
| &nbsp;&nbsp;Eliminations |  |  |  | (22) |
| Consolidated net sales |  |  |  | $3644 |
| Material costs | 1041 | 742 | 581 |  |
| Labor and overhead | 482 | 381 | 115 |  |
| Administrative, engineering and allocated costs | 39 | 53 | 32 |  |
| Equity income |  | 5 | 24 |  |
| Adjusted EBITDA | $80 | $34 | $115 | $229 |
| *Reconciliation to income (loss) before income taxes* |  |  |  |  |
| Corporate-related costs <sup>(1)</sup> |  |  |  | (22) |
| Restructuring and impairment costs <sup>(2)</sup> |  |  |  | (24) |
| Purchase accounting amortization <sup>(3)</sup> |  |  |  | (11) |
| Restructuring-related activities <sup>(4)</sup> |  |  |  | (7) |
| Depreciation expense |  |  |  | (69) |
| Equity based compensation |  |  |  | (8) |
| Other items <sup>(5)</sup> |  |  |  | 2 |
| Net financing charges |  |  |  | (48) |
| Other pension expense |  |  |  | (1) |
| Income (loss) before income taxes |  |  |  | 41 |

---

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments, including restructuring charges of $24 million. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities, including $5 million of restructuring-related charges primarily recorded in cost of sales and a $2 million of restructuring charge at partially-owned affiliates recorded within equity income.

(5) Includes a $2 million gain on a non-recurring contract related settlement recorded in SG&A.

**Adient plc \| Form 10-Q \| 25**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**December 31, 2024** | **Three Months Ended**<br>**December 31, 2024** | **Three Months Ended**<br>**December 31, 2024** | **Three Months Ended**<br>**December 31, 2024** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Consolidated** |
| Segment net sales | $1611 | $1129 | $772 | $3512 |
| &nbsp;&nbsp;Eliminations |  |  |  | (17) |
| Consolidated net sales |  |  |  | $3495 |
| Material costs | 1033 | 712 | 539 |  |
| Labor and overhead | 444 | 353 | 105 |  |
| Administrative, engineering and allocated costs | 49 | 47 | 33 |  |
| Equity income |  | 5 | 16 |  |
| Adjusted EBITDA | $85 | $22 | $111 | $218 |
| *Reconciliation to income (loss) before income taxes* |  |  |  |  |
| Corporate-related costs <sup>(1)</sup> |  |  |  | (22) |
| Restructuring and impairment costs <sup>(2)</sup> |  |  |  | (23) |
| Purchase accounting amortization <sup>(3)</sup> |  |  |  | (11) |
| Restructuring-related activities <sup>(4)</sup> |  |  |  | (1) |
| Gain on disposal transactions <sup>(5)</sup> |  |  |  | 4 |
| Depreciation expense |  |  |  | (69) |
| Equity based compensation |  |  |  | (5) |
| Other items <sup>(6)</sup> |  |  |  | 2 |
| Net financing charges |  |  |  | (45) |
| Other pension expense |  |  |  | (1) |
| Income (loss) before income taxes |  |  |  | 47 |

---

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments, including restructuring charges of $13 million and an impairment charge of $10 million related to Adient's investment in Adient Aerospace. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities, including $6 million in restructuring-related charges primarily recorded in cost of sales, partially offset by a $5 million gain on sale of a restructured facility in Americas recorded in SG&A.

(5) Includes a $4 million gain on sale of its partially-owned investment in Setex recorded within equity income. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.

(6) Includes a $2 million gain on a non-recurring contract related settlement recorded in SG&A.

**Adient plc \| Form 10-Q \| 26**

------

**Additional Segment Information**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2025** | **Three Months Ended December 31, 2025** | **Three Months Ended December 31, 2025** | **Three Months Ended December 31, 2025** | **Three Months Ended December 31, 2025** |
| | **Reportable Segments** | **Reportable Segments** | **Reportable Segments** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| Total Assets | 2804 | 1910 | 3186 | 874 | 8774 |
| Investment in partially-owned affiliates | 2 | 41 | 269 |  | 312 |
| Equity income |  | 5 | 24 | (2) | 27 |
| Depreciation | 31 | 26 | 12 |  | 69 |
| Amortization | 1 |  | 10 |  | 11 |
| Capital Expenditures | 28 | 24 | 13 |  | 65 |

---

<sup>(1)</sup> Corporate-related assets primarily include cash and assets held for sale. Specific reconciling item for equity income represents $2 million of restructuring charges at affiliates.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2024** | **Three Months Ended December 31, 2024** | **Three Months Ended December 31, 2024** | **Three Months Ended December 31, 2024** | **Three Months Ended December 31, 2024** |
| | **Reportable Segments** | **Reportable Segments** | **Reportable Segments** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| Total Assets | 2593 | 2046 | 3025 | 869 | 8533 |
| Investment in partially-owned affiliates | 2 | 41 | 275 |  | 318 |
| Equity income |  | 5 | 16 | 4 | 25 |
| Depreciation | 31 | 27 | 11 |  | 69 |
| Amortization | 3 |  | 8 |  | 11 |
| Capital Expenditures | 27 | 27 | 10 |  | 64 |

---

<sup>(1)</sup> Corporate-related assets primarily include cash and assets held for sale. Specific reconciling item for equity income represents a $4 million one-time gain on the sale of Adient's partially-owned investment in Setex.

**Adient plc \| Form 10-Q \| 27**

------

***Geographic Information***

Revenue by geographic area is as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
| **Net Sales**<br>**(in millions)** | **2025** | **2024** |
| **Americas** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United States | $1468 | $1445 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mexico | 628 | 608 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Americas | 79 | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regional elimination | (533) | (517) |
|  | 1642 | 1611 |
| **EMEA** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Germany | 226 | 209 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Poland | 206 | 201 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Czech Republic | 169 | 176 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Spain | 198 | 181 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sweden | 159 | 139 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Romania | 130 | 126 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other EMEA | 411 | 384 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regional elimination | (294) | (287) |
|  | 1205 | 1129 |
| **Asia** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;China | 425 | 335 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Thailand | 117 | 123 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Korea | 111 | 147 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Japan | 106 | 107 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Asia | 78 | 78 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regional elimination | (18) | (18) |
|  | 819 | 772 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inter-segment elimination | (22) | (17) |
| **Total** | $3644 | $3495 |

---

**16. Nonconsolidated Partially-Owned Affiliates**

Investments in the net assets of nonconsolidated partially-owned affiliates are reported in the investments in partially-owned affiliates line in the consolidated statements of financial position as of December 31, 2025 and September 30, 2025. Equity in the net income of nonconsolidated partially-owned affiliates are reported in the equity income line in the consolidated statements of income (loss) for the three and nine months ended December 31, 2025 and 2024, respectively. Adient maintains total investments in partially-owned affiliates of $312 million and $276 million at December 31, 2025 and September 30, 2025,

**Adient plc \| Form 10-Q \| 28**

------

respectively. Operating information for nonconsolidated partially-owned affiliates is as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Income statement data: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $972 | $1000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | $104 | $79 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $55 | $44 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to the entity | $54 | $43 |

---

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for transactions involving Adient's investments in nonconsolidated partially-owned affiliates.

**17. Commitments and Contingencies**

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product recall, product liability, casualty environmental, safety and health, intellectual property, employment, trade compliance, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Costs related to such matters were not material to the periods presented.

Adient accrues for potential environmental liabilities when it is probable a liability has been incurred and the amount of the liability is reasonably estimable. Reserves for environmental liabilities totaled $3 million at both December 31, 2025 and September 30, 2025. Adient reviews the status of its environmental sites on a quarterly basis and adjusts its reserves accordingly. Such potential liabilities accrued by Adient do not take into consideration possible recoveries of future insurance proceeds. They do, however, take into account the likely share other parties will bear at remediation sites. It is difficult to estimate Adient's ultimate level of liability at many remediation sites due to the large number of other parties that may be involved, the complexity of determining the relative liability among those parties, the uncertainty as to the nature and scope of the investigations and remediation to be conducted, the uncertainty in the application of law and risk assessment, the various choices and costs associated with diverse technologies that may be used in corrective actions at the sites, the often quite lengthy periods over which eventual remediation may occur, and changing environmental laws. Nevertheless, Adient does not currently believe that any claims, penalties or costs in connection with known environmental matters will have a material adverse effect on Adient's financial position, results of operations or cash flows.

**18. Related Party Transactions**

In the ordinary course of business, Adient enters into transactions with related parties, such as equity affiliates. Such transactions consist of the sale or purchase of goods and other arrangements.

The following table sets forth the location and amounts of net sales to and purchases from related parties included in Adient's consolidated statements of income (loss):

---

| | | | |
|:---|:---|:---|:---|
| | | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | | **2025** | **2024** |
| Net sales to related parties | Net sales | $28 | $56 |
| Purchases from related parties | Cost of sales | 91 | 83 |

---

**Adient plc \| Form 10-Q \| 29**

------

The following table sets forth the locations and amount of accounts receivable due from and payable to related parties in Adient's consolidated statements of financial position:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | | **December 31, 2025** | **September 30, 2025** |
| Accounts receivable from related parties | Accounts receivable | $10 | $16 |
| Accounts payable to related parties | Accounts payable/other current liabilities | 40 | 58 |

---

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for transactions involving Adient's investments in nonconsolidated partially-owned affiliates which have impacted Adient's related party transactions.

**Adient plc \| Form 10-Q \| 30**

------

---

| | |
|:---|:---|
| **Item 2.** | **Management's Discussion and Analysis of Financial Condition and Results of Operations** |

---

***Forward-Looking Statements***

*This section and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "can," "may," "forecast," "project," "should," or similar terms. Forward-looking statements are not guarantees of future performance and Adient's actual results may differ significantly from the results discussed in the forward-looking statements. Adient cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Adient's control, that could cause Adient's actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks related to: the effects of local and national economic, credit and capital market conditions (including the persistence of high interest rates, vehicle affordability and volatile currency exchange rates) on the global economy, increased competitive pressures in the EMEA and Asia regions from Chinese OEMs, uncertainties in U.S. administrative policy regarding trade agreements, tariffs and other international trade relations, automotive vehicle production levels, mix and schedules, as well as the concentration of exposure to certain automotive manufacturers particularly new entrants in the China market, shifts in market shares among vehicles, vehicle segments or away from vehicles on which Adient has significant content, changes in consumer demand, risks associated with Adient's joint ventures, volatile energy markets, Adient's ability and timing of customer recoveries for increased input costs, the availability of raw materials and component products (including components required by Adient's customers for the manufacture of vehicles), risks associated with warranty and product recall and product liability exposures, geopolitical uncertainties such as the Ukraine and Middle East conflicts and the impact on the regional and global economies and additional pressure on supply chain and vehicle production, the ability of Adient to effectively launch new business at forecast and profitable levels, the ability of Adient to successfully identify suitable opportunities for organic investment and/or acquisitions and to integrate such investments and/or acquisitions, work stoppages, including due to strikes, supply chain disruptions and similar events, wage inflationary pressures due to labor shortages and new labor negotiations, the ability of Adient to execute its restructuring plans and achieve the desired benefit, the ability of Adient to meet debt service requirements and terms of future financing, the impact of global tax reform legislation, the impact of more aggressive positions taken by tax authorities, potential adjustment of the value of deferred tax assets, global climate change and related emphasis on sustainability matters by various stakeholders, and the ability of Adient to achieve its sustainability-related goals, cancellation of, or changes to, commercial arrangements, and the ability of Adient to identify, recruit and retain key leadership. Additional information regarding these and other risks related to Adient's business that could cause actual results to differ materially from what is contained in the forward-looking statements is included in the section entitled "Risk Factors," contained in this Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2025 and the Annual Report on Form 10-K for the fiscal year ended September 30, 2025. The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included within this report as well as within Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. All information presented herein is based on Adient's fiscal calendar. Unless otherwise stated, references to particular years, quarters, months or periods refer to Adient's fiscal years ended in September and the associated quarters, months and periods of those fiscal years. The forward-looking statements included in this Form 10-Q are made only as of the date of this report, unless otherwise specified, and Adient assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.*

**Overview**

Adient is a global leader in the automotive seating supply industry and maintains relationships with the largest global automotive original equipment manufacturers, or OEMs. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture and deliver complete seat systems and components in every major automotive producing region in the world.

Adient designs, manufactures and markets a full range of seating systems and components for passenger cars, commercial vehicles and light trucks, including vans, pick-up trucks and sport/crossover utility vehicles. Adient operates approximately 200 wholly- and majority-owned manufacturing, assembly or sequencing facilities, with operations in 29 countries. Additionally, Adient has partially-owned affiliates in China, Asia, Europe and North America. Through its global footprint and vertical integration, Adient leverages its capabilities to drive growth in the automotive seating industry.

**Adient plc \| Form 10-Q \| 31**

------

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income (loss) before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring-related costs, net mark-to-market adjustments on pension plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker. Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for additional information on Adient's reportable segments.

**Factors Affecting Adient's Operating Environment**

The results presented below are not necessarily indicative of full-year results as Adient, along with the automotive industry, continues to face a dynamic environment surrounding future production volume. This dynamic environment is the result of a combination of factors experienced over the recent past including softening consumer demand due in part to vehicle affordability, the direct and indirect impacts resulting from the imposition of U.S. and foreign tariffs, market share loss for foreign/luxury OEMs in the Asia reporting unit combined with modest expected margin declines as Adient continues to win new business with local OEMs in China, intensifying competition from Chinese imports and lower exports to China from EMEA as domestic brands expand in China, overcapacity in the EMEA reporting unit resulting in pricing pressure, continued disruptions caused by slower EV adoption rates, and interruptions from other suppliers due to production downtime and shortages of critical components or raw materials. Adient has also been experiencing increased levels of discussions with taxing authorities and more aggressive negotiations by the tax authorities as part of tax audits and related inquiries, resulting in higher levels of uncertainty on tax assessment outcomes. These factors may continue to negatively impact Adient's results in the foreseeable future. Refer to the consolidated results of operations and segment analysis discussion below for additional information on the impacts of these items on Adient's results.

**Global Automotive Industry**

Adient conducts its business globally in the automotive industry, which is highly competitive and sensitive to economic, political and social factors in the various regions. During the three months ended December 31, 2025, global light vehicle production increased 2.1% primarily driven by improved vehicle sales and stronger export activity in Asia.

Light vehicle production levels by geographic region are provided below:

---

| | | | |
|:---|:---|:---|:---|
| | **Light Vehicle Production** | **Light Vehicle Production** | **Light Vehicle Production** |
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(units in millions)** | **2025** | **Change** | **2024** |
| Global | 24.7 | 2.1% | 24.2 |
| North America | 3.5 | (2.8)% | 3.6 |
| South America | 0.8 | —% | 0.8 |
| EMEA | 4.7 | 4.4% | 4.5 |
| China | 9.8 | 3.2% | 9.5 |
| Asia, excluding China, and Other | 5.9 | 1.7% | 5.8 |
| Source: S&P Global, January 2026 | Source: S&P Global, January 2026 |  |  |

---

**Financial Results Summary**

Significant aspects of Adient's financial results for the first quarter of fiscal 2026 include the following:

• Adient recorded net sales of $3,644 million for the first quarter of fiscal 2026, representing an increase of $149 million or 4.3% when compared to the first quarter of fiscal 2025. The increase in net sales is primarily attributable to the favorable

**Adient plc \| Form 10-Q \| 32**

------

impact of foreign currencies, higher overall production volumes in Asia, net of lower overall production volumes in EMEA and Americas, and a net favorable impact of commercial pricing adjustments including customer cost recoveries.

**•** Gross profit was $217 million, or 6.0% of net sales, for the first quarter of fiscal 2026 compared to $216 million, or 6.2% of net sales for the first quarter of fiscal 2025. Profitability was higher due primarily to the favorable impact of foreign currencies more than offsetting the unfavorable impact of production volume/mix and higher year-over-year operating costs.

• Equity income was $27 million for the first quarter of fiscal 2026, compared to $25 million for the first quarter of fiscal 2025. The increase is primarily attributable to favorable operating performance at partially-owned affiliates.

**•** Net loss attributable to Adient was $22 million for the first quarter of fiscal 2026, compared to net income attributable to Adient of zero for the first quarter of fiscal 2025. The net loss in the first quarter of fiscal 2026 is primarily attributable to higher income tax expense, unfavorable production volume/mix and higher SG&A expenses, partially offset by the favorable impact of foreign currencies and a decrease in income attributable to noncontrolling interests.

**Consolidated Results of Operations**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Net sales | $3644 | 4% | $3495 |
| Cost of sales | 3427 | 5% | 3279 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 217 | —% | 216 |
| Selling, general and administrative expenses | 130 | 4% | 125 |
| Restructuring and impairment costs | 24 | 4% | 23 |
| Equity income | 27 | 8% | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and income taxes | 90 | (3)% | 93 |
| Net financing charges | 48 | 7% | 45 |
| Other pension expense | 1 | —% | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 41 | (13)% | 47 |
| Income tax provision | 42 | 91% | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | (1) | >(100%) | 25 |
| Income attributable to noncontrolling interests | 21 | (16)% | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Adient | $(22) | n/a | $— |

---

**Net Sales**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Net sales | $3644 | 4% | $3495 |

---

Net sales increased by $149 million, or 4%, in the first quarter of fiscal 2026 as compared to the first quarter of fiscal 2025 due to the favorable impact of foreign currencies ($98 million), higher production volumes in Asia, net of lower production volumes in EMEA and Americas as a result of softening consumer demand and vehicle production disruptions at certain customers ($41 million) and the net favorable impact of commercial pricing adjustments including customer cost recoveries ($10 million).

**Adient plc \| Form 10-Q \| 33**

------

**Cost of Sales / Gross Profit**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2025** | **Change** | **2024** | **2024** |
| Cost of sales | $| 3427 | 5% | $| 3279 |
| Gross profit | $| 217 | —% | $| 216 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of sales | 6.0% | 6.0% |  | 6.2% | 6.2% |

---

Cost of sales increased by $148 million, or 5%, and gross profit increased by $1 million, or 0.5%, in the first quarter of fiscal 2026 as compared to the first quarter of fiscal 2025. The year over year increase in cost of sales was primarily due to the unfavorable impact of foreign currencies ($85 million), the net impact of higher production volumes in Asia partially offset by lower production volumes in EMEA and Americas ($52 million) and unfavorable net operating performance including increased program launch costs, inefficiencies related to certain customer disruptions and the impact of tariffs partially offset by favorable material cost adjustments ($11 million). Gross profit for the three months ended December 31, 2025 was impacted by the favorable impact of foreign currencies, partially offset by lower production volume/mix and unfavorable net operating performance including increased program launch costs, inefficiencies related to certain customer disruptions and the net impact of tariffs partially offset by favorable material cost adjustments.

Refer to the segment analysis below for a discussion of segment profitability.

**Selling, General and Administrative (SG&A) Expenses**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2025** | **Change** | **2024** | **2024** |
| Selling, general and administrative expenses | $| 130 | 4% | $| 125 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of sales | 3.6% | 3.6% |  | 3.6% | 3.6% |

---

SG&A increased by $5 million, or 4%, year over year primarily due to higher compensation expense including equity and performance-based incentive compensation costs ($9 million), a non-recurring gain on the sale of an asset in the prior year ($5 million) and the unfavorable impact of foreign currencies ($4 million), partially offset by lower net engineering and other administrative spending ($13 million).

**Restructuring and Impairment Costs**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Restructuring and impairment costs | $24 | 4% | $23 |

---

Restructuring and impairment costs increased by $1 million, or 4%, in the first quarter of fiscal 2026 as compared to the first quarter of fiscal 2025. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for information related to Adient's restructuring plans.

**Equity Income**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Equity income | $27 | 8% | $25 |

---

Equity income was $27 million for the first quarter of fiscal 2026, compared to $25 million in the first quarter of fiscal 2025. The increase is primarily attributable to favorable operating performance and volume at partially-owned affiliates ($8 million),

**Adient plc \| Form 10-Q \| 34**

------

partially offset by a one-time gain on the sale of Setex during the first quarter of fiscal 2025 ($4 million) and restructuring-related charges related to certain of Adient's investment in non-consolidated affiliates ($2 million).

**Net Financing Charges**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Net financing charges | $48 | 7% | $45 |

---

Net financing charges were higher by $3 million in the first quarter of fiscal 2026 as compared to the first quarter of fiscal 2025. The increase was primarily due to higher interest expense as a result of higher average interest rates. Refer to Note 8, "Debt and Financing Arrangements," of the notes to the consolidated financial statements for further information related to Adient's debt transactions and components of net financing charges.

**Other Pension Expense**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Other pension expense | $1 | —% | $1 |

---

Other pension expense for the first quarter of fiscal 2026 is unchanged as compared to the first quarter of fiscal 2025. Refer to Note 12, "Retirement Plans," of the notes to the consolidated financial statements for information related to the non-service components of Adient's net periodic pension costs.

**Income Tax Provision**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Income tax provision | $42 | 91% | $22 |

---

The first quarter fiscal 2026 income tax expense of $42 million was higher than the Irish statutory rate of 12.5% primarily due to the establishment of uncertain tax positions associated with a foreign tax audit settlement expected to be finalized in fiscal 2026 and the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by tax benefits related to audit closures and statute expirations. The first quarter fiscal 2025 income tax expense of $22 million was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances and $6 million tax expense related to foreign exchange remeasurements of tax balances primarily in Mexico, partially offset by tax benefits from the release of uncertain tax positions due to statute expirations.

**Income Attributable to Noncontrolling Interests**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Income attributable to noncontrolling interests | $21 | (16)% | $25 |

---

The decrease in income attributable to noncontrolling interests in the first quarter of fiscal 2026 as compared to the first quarter of fiscal 2025 is primarily attributable to lower production volumes at certain affiliates in Asia.

**Adient plc \| Form 10-Q \| 35**

------

**Net Income (Loss) Attributable to Adient**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Net income (loss) attributable to Adient | $(22) | n/a | $— |

---

Net loss attributable to Adient was $22 million for the first quarter of fiscal 2026, compared to net income attributable to Adient of zero for the first quarter of fiscal 2025. The net loss in the first quarter of fiscal 2026 is primarily attributable to higher income tax expense, unfavorable production volume/mix and higher SG&A expenses, partially offset by the favorable impact of foreign currencies and a decrease in income attributable to noncontrolling interests.

**Comprehensive Loss Attributable to Adient**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Comprehensive loss attributable to Adient | $(8) | 96% | $(225) |

---

Comprehensive loss attributable to Adient was $8 million for the first quarter of fiscal 2026 compared to $225 million of comprehensive loss for the first quarter of fiscal 2025. The gain of $217 million is due primarily to the favorable impact of foreign currency translation adjustments ($250 million) and realized and unrealized gains on derivatives in the first quarter of fiscal 2026 compared to losses in the first quarter of fiscal 2025 ($14 million), partially offset by a net loss in the first quarter of fiscal 2026 compared to a net income in the first quarter of fiscal 2025 ($26 million) and higher comprehensive income attributable to noncontrolling interests ($21 million).

**Segment Analysis**

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items. Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

The results presented below are not necessarily indicative of full-year results as Adient, along with the automotive industry, continues to face a dynamic environment surrounding future production volume. This dynamic environment is the result of a combination of factors experienced over the recent past including softening consumer demand due in part to vehicle affordability, the direct and indirect impacts resulting from the imposition of U.S. and foreign tariffs, market share loss for foreign/luxury OEMs in the Asia reporting unit combined with modest expected margin declines as Adient continues to win new business with local OEMs in China, intensifying competition from Chinese imports and lower exports to China from EMEA as domestic brands expand in China, overcapacity in the EMEA reporting unit resulting in pricing pressure along with continued disruptions caused by slower electric vehicle adoption rates, and interruptions from other suppliers due to production downtime and shortages of critical components or raw materials. Adient has also been experiencing increased levels of discussions with taxing authorities and more aggressive negotiations by the tax authorities as part of tax audits and related inquiries, resulting in higher levels of uncertainty on tax assessment outcomes. These factors may continue to negatively impact Adient's results in the foreseeable future. Refer to the Factors Affecting Adient's Operating Environment section in this Form 10-Q and within our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, for additional information on factors that have impacted Adient.

**Adient plc \| Form 10-Q \| 36**

------

Financial information relating to Adient's reportable segments is as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Americas** | **EMEA** | **Asia** | **Corporate/Eliminations** | **Consolidated** |
| *Three months ended December 31, 2025* | *Three months ended December 31, 2025* | *Three months ended December 31, 2025* | *Three months ended December 31, 2025* | *Three months ended December 31, 2025* | *Three months ended December 31, 2025* |
| Net sales | $1642 | $1205 | $819 | $(22) | $3644 |
| Adjusted EBITDA | $80 | $34 | $115 | $(22) | $207 |
| *Three months ended December 31, 2024* | *Three months ended December 31, 2024* | *Three months ended December 31, 2024* | *Three months ended December 31, 2024* | *Three months ended December 31, 2024* | *Three months ended December 31, 2024* |
| Net sales | $1611 | $1129 | $772 | $(17) | $3495 |
| Adjusted EBITDA | $85 | $22 | $111 | $(22) | $196 |

---

The following is a reconciliation of Adient's reportable segments' adjusted EBITDA to income before income taxes:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Adjusted EBITDA |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Americas | $80 | $85 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EMEA | 34 | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asia | 115 | 111 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 229 | 218 |
| Corporate-related costs <sup>(1)</sup> | (22) | (22) |
| Restructuring and impairment costs <sup>(2)</sup> | (24) | (23) |
| Purchase accounting amortization <sup>(3)</sup> | (11) | (11) |
| Restructuring related charges <sup>(4)</sup> | (7) | (1) |
| Gain on disposal transactions <sup>(5)</sup> |  | 4 |
| Depreciation | (69) | (69) |
| Equity based compensation | (8) | (5) |
| Other items <sup>(6)</sup> | 2 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and income taxes | 90 | 93 |
| Net financing charges | (48) | (45) |
| Other pension expense | (1) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | $41 | $47 |

---

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments, including restructuring charges of $24 million and $13 million for the three months ended December 31, 2025 and 2024, respectively. During the first quarter of fiscal 2025, an impairment charge of $10 million related to Adient's investment in Adient Aerospace was recorded. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities. The three months ended December 31, 2025 includes $5 million of

**Adient plc \| Form 10-Q \| 37**

------

restructuring-related charges primarily recorded in cost of sales and $2 million restructuring charge at partially-owned affiliates recorded within equity income. The three months ended December 31, 2024 includes $6 million in restructuring-related charges primarily recorded in cost of sales, partially offset by a $5 million gain on sale of a restructured facility in Americas recorded in SG&A.

(5) The three months ended December 31, 2024 includes a $4 million gain on sale of its partially-owned investment in Setex recorded within equity income. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.

(6) The three months ended December 31, 2025 and 2024 both include a $2 million gain on a non-recurring contract related settlement recorded in SG&A.

***Americas***

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Net sales | $1642 | 2% | $1611 |
| Adjusted EBITDA | $80 | (6)% | $85 |

---

Net sales increased during the first quarter of fiscal 2026 by $31 million primarily due to net favorable commercial pricing adjustments including customer cost recoveries ($29 million) and the favorable impact of foreign currencies ($3 million), partially offset by lower production volumes ($1 million).

Adjusted EBITDA decreased during the first quarter of fiscal 2025 by $5 million due to unfavorable operating performance driven by operating inefficiencies due to production disruption costs related to certain customers, higher program launch costs and the net impact of tariffs ($21 million), unfavorable production volume/mix ($15 million) and lower equity income ($1 million), partially offset by favorable customer pricing actions including customer cost recoveries ($19 million), lower engineering expenses ($11 million) and the favorable impact of foreign currencies ($2 million).

***EMEA***

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Net sales | $1205 | 7% | $1129 |
| Adjusted EBITDA | $34 | 55% | $22 |

---

Net sales increased during the first quarter of fiscal 2026 by $76 million primarily as a result of the favorable impact of foreign currencies ($94 million), partially offset by lower production volumes resulting from weakening consumer demand for new vehicles ($14 million) and an unfavorable impact of net commercial pricing adjustments including customer cost recoveries ($4 million).

Adjusted EBITDA increased during the first quarter of fiscal 2026 by $12 million due to favorable net operating performance reflecting favorable labor and overhead costs and favorable material cost adjustments ($8 million), favorable production volume/mix ($5 million), partially offset by the unfavorable impact of foreign currencies ($1 million).

**Adient plc \| Form 10-Q \| 38**

------

***Asia***

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **Change** | **2024** |
| Net sales | $819 | 6% | $772 |
| Adjusted EBITDA | $115 | 4% | $111 |

---

Net sales increased during the first quarter of fiscal 2026 by $47 million due to higher production volumes ($59 million) and the favorable impact of foreign currencies ($3 million), partially offset by net unfavorable commercial pricing adjustments including customer cost recoveries ($15 million).

Adjusted EBITDA increased during the first quarter of fiscal 2026 by $4 million due to higher equity income resulting from increased sales at a China affiliate ($9 million) and the favorable impact of foreign currencies ($3 million), partially offset by net unfavorable operating performance which includes unfavorable customer pricing adjustments, higher program launch costs and lower material costs ($7 million) and unfavorable production volumes/mix ($1 million).

**Liquidity and Capital Resources**

Adient's primary liquidity needs are to fund general business requirements, including working capital, capital expenditures, restructuring costs, debt service requirements and discretionary spending to repurchase Adient's shares. Adient's principal sources of liquidity are cash flows from operating activities, the revolving credit facility and other debt issuances, and existing cash balances. Adient actively manages its working capital and associated cash requirements and continually seeks more effective uses of cash. Working capital is highly influenced by the timing of cash flows associated with sales and purchases, and therefore can be difficult to manage at times. See below for discussion of Adient's financing arrangements. Adient believes that its current financial resources will be sufficient to fund its liquidity requirements for at least the next twelve months. Fiscal 2026 cash flows are expected to be lower than fiscal 2025 cash flows due primarily to reduced profitability resulting from lower production volumes, higher capital spending to fund growth initiatives, non-recurring tax settlements and an acceleration in the timing of commercial settlements in fiscal 2025.

***Indebtedness***

As of September 30, 2025, Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintained an asset-based revolving credit facility (the "ABL Credit Facility"), which provided for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. During the first quarter of fiscal 2026, Adient amended the ABL Credit Facility, reducing the maximum facility from $1,250 million to $1,000 million (consisting of a North American subfacility of up to $895 million and a European subfacility of up to $105 million). Under the amended agreement, Adient will pay a commitment fee of 0.20% - 0.25% (previously 0.25% to 0.375%) on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Adient incurred $6 million of costs associated with this amendment, which was recorded as deferred financing costs. The amended ABL Credit Facility is set to mature in October 2030 (previously November 2027), subject to certain springing maturity provisions. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the amended ABL Credit Facility then in effect. Subject to certain conditions, the amended ABL Credit Facility may be expanded by up to $500 million in additional commitments. Loans under the amended ABL Credit Facility may be denominated, at the option of Adient, in U.S. Dollars, Euros, Pounds Sterling or Swedish Krona. It also provides flexibility for future amendments to the amended ABL Credit Facility to incorporate certain sustainability-based pricing provisions. The amended ABL Credit Facility is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. Interest is payable on the amended ABL Credit Facility at a fluctuating rate of interest determined by reference to Term SOFR, in the case of amounts outstanding in Dollars, EURIBOR, in the case of amounts outstanding in Euros, STIBOR, in the case of amounts outstanding in Swedish Krona and SONIA, in the case of amounts outstanding in Pounds Sterling, in each case, plus an applicable margin of 1.25% - 1.75% (previously 1.50% to 2.00%). As of December 31, 2025, Adient had not drawn down on the amended ABL Credit Facility and had availability under this facility of $823 million (net of $8 million of letters of credit).

In addition, Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintains a senior secured term loan facility (the "Term Loan B Agreement"), that had an outstanding balance of $624 million and $626 million as of December 31, 2025

**Adient plc \| Form 10-Q \| 39**

------

and September 30, 2025, respectively. During the first quarter of fiscal 2025, the Term Loan B Agreement was amended to reduce the applicable margin from 2.75% to 2.25%. Adient incurred $1 million of costs associated with the modification, which was recorded as deferred financing costs. The maturity date was also extended from April 2028 to January 2031. The amended Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance due at final maturity. The amended Term Loan B Agreement permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. Interest on the amended Term Loan B Agreement accrues at Term SOFR plus an applicable margin. During the second quarter of fiscal 2026, Adient further amended the Term Loan B Agreement to reduce the applicable margin from 2.25% to 2.00%. Adient incurred $1 million of costs associated with this amendment, which was recorded as deferred financing costs.

The amended ABL Credit Facility and amended Term Loan B Agreement contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient's capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient's and its restricted subsidiaries' assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains (i) $500 million in aggregate principal amount of 7.00% senior secured notes due 2028, (ii) $500 million in aggregate principal amount of 8.250% senior unsecured notes due 2031 and (iii) $795 million in aggregate principal amount of 7.50% senior unsecured notes due 2033. Interest on notes (i) and (ii) are paid on April 15 and October 15 each year. Interest on note (iii) is paid on February 15 and August 15 each year. These notes contain covenants that are usual and customary.

***Sources of Cash Flows***

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|<br>**(in millions)** | **2025** | **2024** |
| Cash provided by operating activities | $80 | $109 |
| Cash used by investing activities | (68) | (34) |
| Cash used by financing activities | (114) | (102) |
| Capital expenditures | (65) | (64) |

---

*Operating Cash Flows:* The decrease in cash flows from operating activities is primarily due to lower net income and lower dividend amounts received from partially-owned affiliates, partially offset by lower cash contributions to pension plans. See the working capital section below for more information.

*Investing Cash Flows:* The increase in cash used by investing activities is primarily attributable to proceeds received from the sale of Adient's interest in Setex during the first quarter of fiscal 2025.

*Financing Cash Flows:* The increase in cash used by financing activities is primarily attributable to higher amounts of non-controlling interest dividends paid, partially offset by the acquisition of the noncontrolling interest in Technotrim during the first quarter of fiscal 2025. Refer to Note 11, "Equity and Noncontrolling Interests," of the notes to the consolidated financial statements for additional information.

*Capital expenditures:* Higher capital expenditures during the first three months of fiscal 2026 were due primarily to timing of program spend on product launches.

**Adient plc \| Form 10-Q \| 40**

------

***Working capital***

---

| | | |
|:---|:---|:---|
| **(in millions)** | **December 31, 2025** | **September 30, 2025** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current assets | $3916 | $4133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current liabilities | 3592 | 3687 |
| Working capital | $324 | $446 |

---

Working capital decreased by $122 million primarily due to decreases in net accounts receivable, cash and cash equivalents, partially offset by an increase in inventory and a decrease in VAT payable and accrued compensation.

***Restructuring Costs***

During the first three months of fiscal 2026, Adient committed to restructuring actions ("2026 Plan") resulting in charges of $23 million. Additional charges totaling $1 million related to prior year plans were also recorded during the three months ended December 31, 2025. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA. The 2026 Plan is being implemented in response to manufacturing footprint and structural changes occurring in the global automotive industry and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with the 2026 Plan will primarily occur in fiscal years 2026 and 2027 and are expected to be substantially complete by fiscal year 2027. Adient currently estimates that upon completion of the restructuring actions, the 2026 Plan will reduce annual operating costs by approximately $15 million, which is primarily the result of lower costs of sales and SG&A due to reduced employee-related costs; however, minimal impact to net earnings is expected.

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

***Repurchases of Equity Securities***

In November 2022, Adient's board of directors authorized the repurchase of Adient's ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient's ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. From fiscal 2023 through fiscal 2025, Adient repurchased and immediately retired a total of 17,297,377 ordinary shares. The aggregate amount of cash paid to repurchase the shares was $465 million, all of which had been spent through September 30, 2025. During the first quarter of fiscal 2026, Adient repurchased and immediately retired 1,232,932 of its ordinary shares at an average purchase price per share of $20.27, for an aggregate amount of cash paid of $25 million. As of December 31, 2025, the remaining aggregate amount of authorization remaining under the share repurchase authorization was $110 million.

**Off-Balance Sheet Arrangements** 

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of December 31, 2025, $169 million was funded under these programs compared to $185 million as of September 30, 2025.

Adient also has a program with an external financial institution under which Adient's suppliers can sell their receivables from Adient to the financial institution at their sole discretion. Adient is not a party to the agreements between the participating suppliers and the financial institution. Adient's obligation under the program is to pay the original amounts of supplier invoices

**Adient plc \| Form 10-Q \| 41**

------

to the financial institution on the original invoice dates. No fees are paid and no assets are pledged by Adient. The payment terms for trade payables can range from 45 days to 120 days depending on types of services and goods being purchased. The payment terms for molds, dies and other tools that are acquired as part of pre-production activities are in general longer, and are normally dependent on the terms which Adient has agreed with its customers. As of December 31, 2025, and September 30, 2025, Adient's liabilities related to this program were $109 million and $105 million, respectively. Cash flows related to the program are all presented within operating activities in Adient's consolidated statements of cash flows.

**Effects of Inflation and Changing Prices**

The effects of inflation have historically not been significant to Adient's results of operations. Generally, Adient has been able to implement operating efficiencies to sufficiently offset cost increases, which over time have been moderate. The automotive industry has experienced periods of significant volatility in commodity and other input costs, including steel, petrochemical, freight, energy and labor costs. This price volatility may continue into the future as demand increases and/or supply remains constrained. Price volatility has resulted in an overall increase of input costs for Adient that may not be, or may only be partially, offset through customer negotiations.

**Critical Accounting Estimates and Policies**

See "Critical Accounting Estimates and Policies" under the heading "Item 7" of Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025, for a discussion of critical accounting estimates and policies. There have been no material changes to Adient's critical accounting estimates and policies during the three months ended December 31, 2025.

**New Accounting Pronouncements**

See Note 1, "Organization and Summary of Significant Accounting Policies," of the notes to the consolidated financial statements for a discussion of new accounting pronouncements.

**Other Information**

Not applicable

---

| | |
|:---|:---|
| **Item 3.** | **Quantitative and Qualitative Disclosures About Market Risk** |

---

As of December 31, 2025, Adient had not experienced any adverse changes in market risk exposures that materially affected the quantitative and qualitative disclosures presented in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

---

| | |
|:---|:---|
| **Item 4.** | **Controls and Procedures** |

---

**Evaluation of Disclosure Controls and Procedures**

As of December 31, 2025, Adient's principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act")), which are designed to provide reasonable assurance that we are able to record, process, summarize and report the information required to be disclosed in our reports under the Exchange Act within the time periods specified in SEC rules and forms. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to management, and made known to our principal executive officer and principal financial officer, on a timely basis to ensure that it is recorded, processed, summarized and reported within the time period specified in the SEC's rules and forms.

**Adient plc \| Form 10-Q \| 42**

------

**Changes in Internal Control over Financial Reporting**

During the first quarter of fiscal 2026, Adient continued to implement a new enterprise resource planning ("ERP") system at certain of its entities in China. The implementation of the ERP system is planned to occur in phases over the coming year for all majority owned entities in China. There were no other changes in internal control over financial reporting during the three months ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Adient plc \| Form 10-Q \| 43**

------

**PART II - OTHER INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Legal Proceedings** |

---

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, trade and other regulatory compliance, commercial and contractual matters and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Adient accrues for potential liabilities in a manner consistent with accounting principles generally accepted in the United States; that is, when it is probable a liability has been incurred and the amount of the liability is reasonably estimable.

Information with respect to this item may be found in Note 17, "Commitments and Contingencies," of the notes to the consolidated financial statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.

Additional information on Adient's commitments and contingencies can be found in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

---

| | |
|:---|:---|
| **Item 1A.** | **Risk Factors** |

---

There are no material changes from the risk factors as previously disclosed in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

---

| | |
|:---|:---|
| **Item 2.** | **Unregistered Sales of Equity Securities and Use of Proceeds** |

---

**(a) Unregistered Sale of Equity Securities**

None.

**(b) Use of Proceeds**

None.

**(c) Repurchase of Equity Securities**

Share repurchase activity during the three months ended December 31, 2025 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Periods** | **Total Number of Shares (or Units) Purchased** | **Average Price Paid per Share (or Unit)** | **Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs** | **Approximate Dollar Value of Shares (or Units) that may yet be Purchased Under the Plans or Programs**<br>**(in millions)**<sup>(1)</sup> |
| October 1 to October 31, 2025 |  | $— |  | $135 |
| November 1 to November 30, 2025 | 1232932 | 20.27 | 1232932 | 110 |
| December 1 to December 31, 2025 |  |  |  | 110 |
|  | 1232932 | $20.27 | 1232932 | $110 |

---

**Adient plc \| Form 10-Q \| 44**

------

(1) In November 2022, Adient's board of directors authorized the repurchase of Adient's ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient's ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. Repurchased shares were retired immediately upon repurchase.

---

| | |
|:---|:---|
| **Item 3.** | **Defaults Upon Senior Securities** |

---

None.

---

| | |
|:---|:---|
| **Item 4.** | **Mine Safety Disclosures** |

---

Not applicable.

---

| | |
|:---|:---|
| **Item 5.** | **Other Information** |

---

During the first quarter of fiscal year 2026, none of Adient's directors or executive officers adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as those terms are defined in Item 408(a) of Regulation S-K.

On January 30, 2026, the Human Capital and Compensation Committee of Adient's Board of Directors approved a one-time restricted stock unit retention award for James J. Huang, Adient's Executive Vice President, APAC (the "Special RSU Award"), pursuant to Adient's 2021 Omnibus Incentive Plan based on the centrality of his role in fiscal year 2026 and his key contributions to date. The Special RSU Award has a grant date of February 5, 2026 and a grant date fair value in an amount equal to $750,000. The Special RSU Award granted to Mr. Huang will vest in full on December 31, 2027 (subject to continued vesting upon an involuntary termination without cause, or accelerated vesting upon death or disability). The terms of the Special RSU Award will be reflected in a form of Restricted Shares or Restricted Share Unit Award Agreement (the "Special RSU Agreement"), which was filed as Exhibit 10.42 to Adient's Annual Report on Form 10-K filed November 18, 2024 and incorporated by reference herein. The foregoing description of the Special RSU Agreement is not complete and is qualified in its entirety by the full text of the Special RSU Agreement.

**Adient plc \| Form 10-Q \| 45**

------

---

| | |
|:---|:---|
| **Item 6.** | **Exhibits** |

---

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit No.** | **Exhibit Title** |
| 10.1 | <u>[Amendment No. 5 dated January 15, 2026 to the Term Loan Credit Agreement dated as of May 6, 2019, among the Borrowers, the lenders party hereto, and the Agent (incorporated by reference to Exhibit 10.1 to Adient plc's Current Report on Form 8-K filed January 16, 2026)(File No. 1-37757).](https://www.sec.gov/Archives/edgar/data/1670541/000167054126000007/adient-2026tlbrepricingxco.htm)</u> |
| 10.2 | <u>[Service Agreement, dated January 1, 2026, entered into between Adient Germany Ltd. & Co. KG and David J. Herberg (File No. 1-37757)).\*](a12312025exhibit102.htm)</u> |
| 31.1 | <u>[Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](a12312025exhibit311.htm)</u> |
| 31.2 | <u>[Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](a12312025exhibit312.htm)</u> |
| 32.1 | <u>[Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](a12312025exhibit321.htm)</u> |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101) |

---

 

\* Denotes management contract or compensatory plan or arrangement required to be filed as an exhibit hereto.

**Adient plc \| Form 10-Q \| 46**

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| Adient plc | Adient plc |
| By: | /s/ Jerome J. Dorlack |
|  | Jerome J. Dorlack |
|  | President and Chief Executive Officer |
| Date: | February 4, 2026 |
| By: | /s/ Mark A. Oswald |
|  | Mark A. Oswald |
|  | Executive Vice President and Chief Financial Officer |
| Date: | February 4, 2026 |

---

**Adient plc \| Form 10-Q \| 47**

## Exhibit 10.2

Exhibit 10.2

**SERVICE AGREEMENT**

between

**Adient Germany Ltd. & Co. KG,<br>Industriestraße 20-30, 51399 Burscheid**

(hereinafter referred to as 'Adient')

and

**Dr.-Ing. David Johannes Herberg,<br>Platzer Höhenweg 25, 51429 Bergisch Gladbach**

**Preamble** 

Effective 1 January 2026, you will assume the role as Executive Vice President, EMEA.

In this capacity, you will be appointed as Company Director of Adient Holding Europe Ltd. (Adient's general partner - *Komplementärin*) with effect from January 15, 2026 and you will manage Adient's business (*Geschäftsleitung*) in EMEA and act as the legal representative of Adient.

The basis for your work is the following new Service Agreement (*Dienstvertrag*), which is to conclusively govern the mutual rights and duties of the contracting parties with effect from January 15, 2026. Adient on the one hand and you on the other agree that all written or oral agreements made to date regarding your previous employment relationship (*Arbeitsverhältnis*) are cancelled by this subsequent Service Agreement and removed and replaced by the following provisions:

**1. Responsibilities und Scope of Duties**

**1.1**Effective 1 January 2026, you are employed as Executive Vice President, EMEA. You shall conduct Adient's business with the diligence of a prudent businessperson and in accordance with statutory law, the articles of association, the resolutions of Adient's partners' meeting, the Service Agreement and the rules of procedure for the management as amended at any time. You will report to Adient's President & CEO.

**1.2**You are not a legal organ (*Organ*) of Adient. Adient is represented vis-à-vis third parties by Adient Holding Europe Ltd. as general partner. Adient Holding Europe Ltd. will grant you procuration (Prokura) or other commercial authority; scope and any limitations will be set out in a separate power of attorney.

------

**1.3**We expect you to use your initiative in the pursuit of the goals of Adient in a responsible manner and, in particular, to accept the binding nature of the Ethics Policy which shall apply in the version in effect from time to time. You acknowledge that compliance with the principles of the Ethics Policy and adherence to the rules of conduct stipulated therein constitute a particularly important contractual obligation. You are responsible for setting the 'tone at the top' within the region for conducting business ethically and with integrity.

**1.4**You have previously signed a declaration to the effect that you are to assume entrepreneurial duties to prevent accidents at the workplace in accordance with your duties as a member of the management. This declaration continues to apply and is an integral part of this Agreement.

**2. Place of Work, Scope of Duties, Secondary Employment**

**2.1**Your primary place of work is Burscheid. The role requires regular domestic and international travel.

**2.2**You shall devote all your work efforts, know-how and ability to the business of Adient. Your working hours shall depend on the requirements and needs of the operation. This shall include the obligation to work on Saturdays, Sundays and public holidays and to conduct business travels if required.

**2.3**The assumption of any secondary self-employed or employed activity, for or without remuneration, requires the prior written consent of Adient's President & CEO. Such consent may be given at the discretion of the President & CEO. Consent granted for the assumption of such activity may be revoked at any time, with it being understood that the secondary employment activity must be discontinued immediately in the event of revocation. If you have assumed a position of advisory or supervisory board member on the basis of the consent granted to you, in the event of its revocation you must resign from this office at the earliest possible date in accordance with the provisions applicable here.

**3. Remuneration**

**3.1**Effective 1 January 2026, your employment activities are remunerated with a gross yearly salary of € 450,000.00 (in words: Euro four hundred fifty thousand 00/100), which shall be paid in monthly instalments in accordance with the company's pay practices.

**3.2**The remuneration pursuant to Section 3.1 above is in settlement of your entire activities. You are not entitled to receive remuneration for overtime work, work on Saturdays, Sundays and public holidays, holiday pay or Christmas bonuses.

**3.3**After deduction of the statutory duties and taxes, your remuneration will be paid in accordance with the operational modalities by non-cash transfer onto an account in Germany to be specified by you.

D. Herberg Service Agreement January 2026

------

**3.4**Your salary will be reviewed annually in accordance with our company regulations. Any change to your yearly salary is subject to approval of the Human Capital and Compensation Committee ("HCCC") of the Adient plc Board of Directors. The HCCC typically reviews and approves compensation of executives in November each year.

**4. AIP Bonus** 

**4.1**You will be eligible to participate in Adient's Annual Incentive Plan ("AIP"). Effective 1 January 2026, your individual bonus target shall be increased to 100% of your gross annual salary, provided that Adient sets up a bonus plan in the respective fiscal year. Both the eligibility requirements and the type and scope are governed by the respective provisions of the AIP. Company performance results, individual payout amount for fiscal year 2026, as well as future individual bonus targets and payout amounts, shall be subject to approval of the HCCC.

**4.2**In case your gross annual salary and/or bonus percentage changes during a fiscal year (such as is the case for fiscal year 2026), your bonus will be calculated on a pro-rated basis taking your previous and current gross annual salary and/or bonus percentage into account.

**4.3**For months in which the service relationship is wholly or partially suspended, no claim exists to a bonus payment.

**5. Company Car**

In your function pursuant to Section 1.1 above you will be entitled to a company car. As you already have a company car in your possession and have signed a car agreement, no further action is needed. The Adient Company Car Guidelines in effect from time to time shall continue to apply accordingly.

**6. Company Pension**

Your direct insurance (*Direktversicherungsvertrag*) with Allianz (policy no. AL-1711108867) will continue under the existing terms and conditions.

**7. Key Executive Severance Agreement**

You have entered into a Key Executive Severance and Change of Control Agreement ("KESA"), attached to this Agreement as **Annex 1.** Among other things, the KESA regulates the payment of severance pay upon termination of the service relationship, a post-contractual non-competition clause and other rights and obligations.

**8. Beginning and Duration of the Service Agreement**

**8.1**This Service Agreement starts on January 15, 2026 and is concluded for an indefinite term.

D. Herberg Service Agreement January 2026

------

**8.2**This Service Agreement may be ordinarily terminated by either party with six (6) months' notice to the end of a calendar month. The right of extraordinary termination pursuant to § 626 of the German Civil Code (BGB) remains unaffected.

**8.3**Notice of termination requires the written form.

**8.4**Notwithstanding Section 8.2 above, this Service Agreement terminates without notice of termination at the latest upon expiry of the month in which you reach the statutory regular age pension (at present, upon completion of 67 years of age).

**8.5**In addition, this Service Agreement terminates without notice of termination upon expiry of the month in which you receive a notice from a pension insurance institution about the granting of a permanent pension due to full reduction in earning capacity. If the pension first starts after receipt of the pension notice, the service agreement terminates upon expiry of the day preceding the start of the pension. However, if you are severely disabled or considered equivalent thereto within the meaning of Book IX of the German Social Code (SGB), the Service Agreement does not terminate until receipt of the approval notice from the integration office (*Integrationsamt*). In such case, you must disclose the severe disability to us without delay.

**8.6**You are obligated to notify us within two weeks if you meet the statutory requirements for drawing an uncurtailed statutory retirement pension or if you receive a notice about the determination of full reduction in earning capacity. You also undertake to notify Adient at all times upon request about the status of applications that you have filed for a retirement pension or a pension due to reduction in earning capacity.

**8.7**Upon your Service Agreement coming to an end, you are required to return, without having to be specifically asked, all objects, keys, company car, including petrol card, credit cards, computer, laptop, mobile phone, access cards, working documents, identity cards, diagrams, notes, books, models, tools, material, etc. provided to you by Adient for the purpose of carrying out your activities. Rights of retention are excluded.

**9. Inability to Work**

**9.1**You are obliged to promptly notify your direct superior (Adient's President & CEO) if you are unable to work for an extended period due to sickness, illness or disability.

**9.2**In the event of incapacity to work due to sickness or illness, you shall continue to receive your previous remuneration in accordance with Section 3 for up to six weeks after you became unable to work, but in no event later than the termination of the Service Agreement.

**9.3**Adient may request, at any time, a doctor's certificate concerning the existence of inability to work and its presumable duration. You declare your willingness to undergo a medical

D. Herberg Service Agreement January 2026

------

examination at Adient's demand if the inability to work persists. The costs incurred hereby will be borne by Adient.

**10. Continued Payment of Salary in case of Death**

In the event of your death, your partner or another defined person (_________________________ please fill in a name) will receive death benefit for the month of your death as well as for the three subsequent months in the amount of your last gross monthly salary as a one-off payment. This benefit must be taxed by the recipient pursuant to the applicable law. Insofar as no partner is named above, or if this person is already deceased at the time of your death, your dependents, as joint creditors, shall receive the aforementioned payment. The death benefit claim must be asserted by the beneficiaries directly vis-à-vis Adient by provision of proof in the form of appropriate documentation.

**11. Holiday**

**11.1**You have a holiday claim in the amount of 30 work days per calendar year. Adient's business interests must be taken into account when scheduling the holiday.

**11.2**Compensation for unused holiday entitlement at the end of the service relationship is excluded.

**12. Data Protection**

**12.1**You are aware that your personal data is processed in connection with this service relationship. Details about this, as well as about your rights associated with processing, can be found in the "Data Protection Policy for Personal Data of Employees and Applicants", as amended, which can be viewed at www.adient.com/dataprivacy.

**12.2**If you are given access to personal data in connection with your service activities, you undertake to comply with the applicable provisions of data protection law. The declaration concerning the "Obligation to Maintain Confidentiality", which was previously signed by you, shall continue to apply.

**13. Inventions/Rights to Works Produced**

**13.1**Inventions made by you during the term of this Service Agreement are the exclusive property of Adient. This also applies to technical and organisational improvement proposals that result directly or indirectly from or are in connection with your tasks.

**13.2**You are obliged to notify Adient's President & CEO without undue delay in writing of inventions and improvement proposals and to assist Adient in obtaining patent protection and other industrial property rights.

D. Herberg Service Agreement January 2026

------

**13.4**You have no claim to separate remuneration for inventions and improvements or the concession and granting of the rights; your performance is compensated with the remuneration agreed in Section 3. No additional remuneration is granted for this.

**14. Exclusion Periods**

**14.1**Except as provided in Section14.3 below, all mutual claims from the Service Agreement and such connected to the service relationship must be asserted in textual form within three months of their becoming due, with the expiration of the term the claim forfeits.

**14.2**If the other party refuses the claim or does not issue any declaration within one month of the assertion of the claim, this claim shall be forfeited if it is not asserted in court within three months of the refusal or the expiry of the one-month term.

**14.3**These preclusive periods do not apply to a) claims of the company under Adient's Executive Incentive Recoupment Policy; b) claims based on willful or grossly negligent conduct or claims in tort; c) cases of injury to life, physical wellbeing and health; and d) claims of the employee to the minimum wage pursuant to the Minimum Wage Act (*Mindestlohngesetz*).

**15. Miscellaneous**

**15.1**This Service Agreement replaces all previous agreements between the Parties. Your calculated start date is 1 April 2011.

**15.2**The possible invalidity of individual provisions of this Service Agreement does not affect the validity of the remaining contractual provisions. The invalid regulation must be replaced by a valid regulation that comes closest to the economic and legal intent of the Parties.

**15.3**There are no side agreements to this Service Agreement, except the KESA and applicable award agreements for any long-term incentive awards under Adient's 2021 Omnibus Incentive Plan.

**15.4**Amendments, supplementations, and the termination of this Service Agreement must be made in writing in order to be effective. The same applies to the amendment of this written-form clause itself. The foregoing written-form requirement does not apply to verbal understandings made directly between the parties after conclusion of contract.

D. Herberg Service Agreement January 2026

------

**15.5**German law shall apply to all legal disputes arising from and in connection with this Service Agreement. To the extent permissible, Burscheid is agreed as the place of jurisdiction.

You confirm that you have received a copy of this Service Agreement properly signed by Adient.

Burscheid, January 15, 2026

---

| | |
|:---|:---|
| Adient Germany Ltd. & Co. KG |  |
| <u>/s/ Nebahat Gueler&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> | <u>/s/ Holger Brueggen&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
| Nebahat Gueler  | Holger Brueggen  |
| Vice President, Human Resources EMEA | Director HR  |

---

<u>/s/ David J. Herberg</u> 

David J. Herberg

D. Herberg Service Agreement January 2026

------

**Annex 1**

**KEY EXECUTIVE SEVERANCE AND CHANGE OF CONTROL AGREEMENT**

**THIS AGREEMENT** (this "<u>Agreement</u>"), is made and entered into as of the 15th day of January 2026 (the "<u>Effective Date</u>"), by and among Adient plc (along with any successor thereto, the "<u>Company</u>"), Adient US LLC and David J. Herberg (the "<u>Executive</u>").

**<u>BACKGROUND</u>**

The Executive is employed by Adient Germany Ltd. & Co. KG (the "Employer") in a key executive capacity. The parties desire to provide the Executive with certain compensation and benefits in the event the Executive's employment with the Employer is terminated under certain circumstances, and to provide certain protections in the event of a change of control of the Company. In addition, the Executive possesses intimate knowledge of the business and affairs of the Company and its affiliates (the Company and all affiliates are collectively referred to herein as the "<u>Company Group</u>") and has acquired certain confidential information and data with respect to the Company Group, which the Company desires to ensure is protected.

**NOW, THEREFORE,** in consideration of the foregoing and of the mutual covenants and agreements hereinafter set forth, the parties hereto mutually covenant and agree as follows:

**ARTICLE I<br><u>TERM</u>**

This Agreement shall become effective on the Effective Date and shall continue until October 1, 2027 (the "<u>Initial Term</u>"). Thereafter, this Agreement shall renew automatically for successive one-year renewal periods unless and until any party provides written notice to the other parties of the intent not to renew this Agreement at least ninety (90) days prior to the end of the Initial Term or any subsequent one-year term. Nonrenewal of this Agreement by any party shall not trigger payment of severance benefits under this Agreement. If this Agreement expires without severance benefits becoming payable hereunder, then the Executive will be eligible to receive severance benefits following the expiration of this Agreement pursuant to the Employer's severance policy as then in effect.

Notwithstanding the foregoing, if a Change of Control (as defined below) occurs prior to the end of the Initial Term or any subsequent one-year term, then the term of the Agreement shall be extended automatically until the second anniversary of such Change of Control (the "<u>Change of Control Period</u>"). For purposes of this Agreement, a "<u>Change of Control</u>" shall have the meaning given in the Adient plc 2021 Omnibus Incentive Plan, or any successor or replacement plan thereto.

**ARTICLE II<br><u>SEVERANCE BENEFITS</u>**

**Section 2.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Eligibility for Severance Benefits</u>.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Eligibility</u>. If the Executive's Separation from Service (as defined below) occurs due to (i) a termination by the Company Group for reasons other than Cause (as defined below), death or disability, or (ii) a resignation for Good Reason (as defined below), and if the Executive complies with the requirements of Section 2.03, then the Executive shall be entitled to the benefits described in Section

D. Herberg Service Agreement January 2026

------

2.02. For purposes hereof, if such a Separation from Service occurs during the Change of Control· Period, then such separation is referred to as a "<u>Change</u> <u>of Control Termination</u>."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Definitions</u>. For purposes of this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i."<u>Cause</u>" shall mean any of the Executive's (A) substantial failure (other than due to the Executive's disability) or refusal to perform the essential duties and responsibilities of his or her job as required by the Employer; (B) material violation of any fiduciary duty owed to the Company Group; (C) conviction of, or entry of a plea of no contest with respect to (1) a felony or (2) a misdemeanor which involves dishonesty, fraud or morally repugnant behavior; (D) dishonesty or theft in connection with the Company Group; (E) a material violation of any of the Company Group's material rules or material policies applicable to the Executive; or (F) other egregious or morally repugnant conduct that has, or could have, a serious and detrimental impact on the Company Group or its employees. The Human Capital and Compensation Committee of the Board of Directors of the Company (the "<u>Committee</u>") shall determine, in good faith and exercising reasonable judgment, whether Cause exists.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii."<u>Good Reason</u>" shall mean the occurrence of one of the following events without the Executive's written consent:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.Before or after the Change of Control Period: (1) a change in the principal geographic location at which the Executive must perform services to a location that is more than thirty (30) miles outside of Burscheid, Germany; or (2) a material reduction to the Executive's total cash compensation target or equity award value target; *provided* that a material reduction to any of the aforementioned will not give rise to a Good Reason if such material reduction is the result of a widespread reduction in compensation applied consistently to other peer executives.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.During the Change of Control Period: (1) an event described in clause A(1) above; (2) either (x) a material reduction to the Executive's total cash compensation target or equity award value target from the levels in effect immediately prior to the Change of Control Period or (y) the application of performance goals to the Executive's incentive compensation awards for which the probability of attainment is materially more difficult than the probability of attainment applicable to the goals under the Company Group's incentive plans as in effect immediately prior to the Change in Control; (3) the assignment to the Executive of any duties inconsistent in any material respect with the Executive's authority, duties or responsibilities as in effect immediately prior to the Change of Control Period which represent a diminution of such duties, or any other action by the Company Group which results in a material diminution in such authority, duties or responsibilities; or (4) a material diminution of the duties or responsibilities of the Executive such that the position held is no longer commensurate with that of a regional Executive Vice President.

The Executive shall be considered to resign for Good Reason under Section 2.01(b)(ii)(A) or (B) only if the Executive provides, within ninety (90) days

D. Herberg Service Agreement January 2026

------

after the Good Reason event, a written notice to the Company in accordance with Section 5.03 specifying in reasonable detail the events or conditions causing Good Reason. Within thirty (30) days after receipt of such notice, the Company Group shall have the opportunity, but shall have no obligation, to cure such events or conditions that give rise to the Good Reason resignation. If the Company Group does not cure such events or conditions within the thirty (30)-day period, the Executive's resignation for Good Reason will be effective at the end of such thirty (30) day cure period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii."<u>Separation</u> <u>from Service</u>" (or derivations thereof) means the legal termination of the employment relationship upon expiration of the notice period.

**Section 2.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Amount of Severance Benefits</u>.** Subject to the conditions of Sections 2.01 and 2.03, the Employer (or, in the case of Section 2.02(c), the Company) shall pay or provide the Executive with the following severance benefits:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Salary Replacement Benefits</u>. A cash payment equal to one (1.0) times the Executive's annual base salary, or, in the event of a Change of Control Termination, a cash payment equal to two and one-half (2.5) times the sum of (i) the Executive's annual base salary and (ii) the Executive's Average Bonus Amount.

For purposes hereof, the "<u>Average</u> <u>Bonus</u> <u>Amount</u>" means the average gross annual cash bonuses paid (or if earned, payable), to the Executive by the Employer in respect of the three fiscal years immediately preceding the fiscal year in which the Executive's Separation from Service occurs. All annual bonus amounts used to determine the Average Bonus Amount shall be determined without regard to any mandatory or voluntary deferrals of such amounts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Bonus</u>. A cash payment of his or her annual bonus for the fiscal year in which the Separation from Service occurs, determined based on actual performance at the end of the applicable performance period, and prorated to reflect the length of employment during the performance period; *provided* that, in the event of a Change of Control Termination, the annual bonus will not be subject to proration.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Equity Awards</u>. Unless an award agreement provides a more favorable result, the Executive's equity awards shall vest on a prorated basis, based on the portion of the vesting or performance period, as applicable, which the Executive has completed at the time of the Executive's Separation from Service, *provided* that all performance based awards shall vest at the end of the performance period only if and to the extent the performance goals thereunder are achieved.

**Section 2.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Additional Requirements to Receive</u> <u>Severance Benefits</u>.** In order to receive severance benefits, the Executive must: (a) execute a release in the form provided by the Company Group within the time period specified in such release, and not revoke such release during the revocation period provided in such release; and (b) comply with all the terms and conditions of such release and the covenants set forth in Article Ill. If the Employer determines that the Executive has not fulfilled these requirements, or if the Committee determines after the Executive's Separation from Service that the Executive (i) has engaged in conduct that constitutes Cause at any time prior to the Executive's Separation from Service (and the facts underlying the Cause determination were not fully known to the Employer at the time of such Separation from Service) or (ii) has been convicted of or entered a plea of no contest with respect to a crime based on conduct which occurred prior to the Executive's Separation from Service, then the Employer may discontinue the payment or provision of the

D. Herberg Service Agreement January 2026

------

severance benefits, and may require the Executive to repay any portion of the severance benefits already received under this Agreement upon written notice. The form of release provided by the Employer shall contain provisions that are typical for such releases and may contain the covenants set forth in Article Ill, but modified as the Employer deems reasonably necessary to ensure compliance with the maximum time, service, scope, geographic or other limitations, as the case may be, permitted by applicable laws.

![image_0.jpg](image_0.jpg)

**Section 2.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Payment</u>.** The cash severance benefits shall be paid in a single lump sum payment within ninety (90) days following the Executive's Separation from Service, or shall be paid in such amounts during such period (not to exceed the number of months of continuation pay represented by the amount of the benefit following the Executive's Separation from Service), as is determined in the sole discretion of the Committee. The annual bonus amount payable pursuant to Section 2.02(b) shall be paid at the same time as bonuses would be payable under the applicable bonus or incentive plan or program. The equity awards that vest pursuant to Section 2.02(c) shall be paid or settled at the time provided in such awards. All payments under this Agreement are subject to applicable federal, state and local taxes and withholdings. In the event of the Executive's death prior to receiving the full cash payment due to him or her, the remaining amount of such payment shall be paid to the Executive's estate in a single lump-sum payment within thirty (30) days following the Executive's death, to the extent practicable, or otherwise at the time when the Executive would have been entitled to the payment had the Executive survived.

**Section 2.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination for Cause, Death, Disability and Voluntary Resignation</u>.** If the Employer terminates the Executive's employment for Cause or if the Executive's employment is terminated due to death, disability or voluntary resignation (that is not for Good Reason), then the Executive shall not be entitled to receive any severance benefits under this Agreement and shall be entitled only to those benefits that are legally required to be provided to the Executive. The Employer may withhold paying severance benefits and the Company may delay causing any equity awards to vest under this Agreement pending prompt resolution of any good faith inquiry that is likely to lead to a finding resulting in Cause.

**Section 2.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Offset to Severance Benefits</u>.** To the extent consistent with law, the Company Group reserves the right to offset from any severance benefits due hereunder, the amount of any monies owed to the Company Group by the Executive or the value of Company Group property that the Executive has retained in his or her possession. Prior to such offset, the Company Group shall provide a written accounting to the Executive of the monies owed or the value of the property for which the offset applies.

**ARTICLE** Ill

**<u>RESTRICTIVE COVENANTS</u>**

D. Herberg Service Agreement January 2026

------

**Section 3.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Confidential Information</u>.** The Executive agrees that, during his or her employment with the Employer and for three years thereafter, the Executive shall hold for the benefit of the Company Group all secret or confidential information, knowledge, or data relating to the Company Group and their respective businesses ("<u>Confidential</u> <u>Information</u>"), which shall .have been obtained by the Executive during the Executive's employment by the Employer or during his or her consultation with the Company Group after his termination of employment, and which is not public knowledge (other than by acts by the Executive or representatives of the Executive in violation of this Agreement). Except in the good faith performance of his or her duties for the Company Group, the Executive shall not, without the prior written consent of the Company or as may otherwise be required by law or legal process, communicate or divulge any such information, knowledge, or data to anyone other than the Company Group and those designated by it. Nothing in this Section 3.01 is intended or shall be construed to limit in any way Section 3.02.

**Section 3.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Trade Secrets</u>.** During employment with the Employer, the Executive shall preserve and protect Trade Secrets (as defined below) of the Company Group from unauthorized use or disclosure, and after termination of such employment, the Executive shall not use or disclose any Trade Secret of the Company Group until such time as that Trade Secret is no longer a secret as a result of circumstances other than a misappropriation involving the Executive. For purposes of this Agreement, "<u>Trade Secret</u>" means information of the Company Group, including a formula, pattern, compilation, program, device, method, technique, or process, that derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use, and that is the subject of efforts by the Company Group to maintain its secrecy that are reasonable under the circumstances.

**Section 3.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Competition</u>.** The Executive agrees that, while the Executive is employed by the Employer and if the Executive experiences a Separation from Service entitling him or her to severance benefits, during the twelve (12) months after such Separation from Service (the "<u>Restricted</u> <u>Period</u>"), the Executive shall not, except as permitted by the Company's prior written consent, in any capacity in which Confidential Information or Trade Secrets of the Company Group would reasonably be regarded as useful, engage in, be employed by, or in any way advise or act for any business that competes with the Company Group (a) with respect to any products or services provided by any division or group within the Company Group in the year immediately preceding the Executive's termination of employment with the Employer and (b) within the national and international geographic markets served by any such division or group. This restriction shall also apply to any ownership or other financial interest in any such competing business except the ownership of less than 5% of the shares of any corporation whose shares are listed on a recognized stock exchange or trade in an over-the-counter market. The Executive acknowledges and agrees that this Section 3.03 applies to the geographic area of Europe, China and the USA. For the avoidance of doubt, and without limitation, the following entities, among others, currently compete with the Company Group: Magna International Inc., Lear Corp., Faurecia SE, Toyota Boshoku Corp., DYMOS, Brose Fahrzeugteile GmbH & Co., Brose Sitech GmbH, Woodbridge Foam Corp., TS Tech Co., Ltd., Tachi-S Co., Ltd., Yanfeng International Seating Systems Co., Ltd., Irvin Automotive Products Inc. and Fisher Dynamics Corp. Employee hereby acknowledges and agrees that the Severance Benefits in Section 2.02 shall be sufficient to compensate him for non-competition during the Restricted Period.

**Section 3.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Solicitation</u>.** The Executive agrees that, during the Restricted Period, the Executive shall not, directly or indirectly, (a) solicit, induce or attempt to induce any individual who is, on the date of the Executive's Separation from Service (or was, during the six-month period prior to the date of Separation from Service), employed by the Company Group in an e-band salaried position to terminate or refrain from renewing or extending such employment or to become employed by or become

D. Herberg Service Agreement January 2026

------

a consultant to any other individual or entity other than the Company Group; or (b) induce or attempt to induce any customer or investor (in each case, whether former, current, or prospective), supplier, licensee, or other business relation of the Company Group to cease doing business with the Company Group, or in any way interfere with the relationship between any such customer, investor, supplier, licensee, or business relation, on the one hand, and the Company Group on the other hand.

**Section 3.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Disparagement</u>.** The Executive agrees that, following the Executive's Separation from Service, the Executive shall not make any public statements that materially disparage the Company Group.

**Section 3.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Equitable Remedies</u>.** The Executive acknowledges that the Company Group would be irreparably injured by a violation of this Article Ill and the Executive agrees that the Company Group, in addition to any other remedies available to it for such breach or threatened breach, on meeting the standards required by law, shall be entitled to a preliminary injunction, temporary restraining order, or other equivalent relief, restraining the Executive from any actual or threatened breach of this Article Ill. If a bond is required to be posted in order for the Company Group to secure an injunction or other equitable remedy, the parties agree that said bond need not be more than a nominal sum.

**Section 3.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability; Blue Pencil</u>.** The Executive acknowledges and agrees that the Executive has had the opportunity to seek advice of counsel in connection with this Agreement and the restrictive covenants contained herein are reasonable in geographical scope, temporal duration and in all other respects. If it is determined that any provision of this Article Ill is invalid or unenforceable, the remainder of the provisions of this Article Ill shall not thereby be affected and shall be given full effect, without regard to the invalid or unenforceable portions. If any court or other decision-maker of competent jurisdiction determines that any of the covenants in this Article III are invalid or unenforceable because of the duration, geographic scope or other limitation of such provision, then the duration, scope or other limitation of such provision, as the case may be, shall be modified to the minimum extent needed so that such provision becomes valid and enforceable, and in its modified form, such provision shall be enforced.

**Section 3.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Whistleblower Rights</u>.** Notwithstanding any provision of this Agreement to the contrary, the covenants set forth in this Article Ill are not intended to (a) interfere with the Executive's right and responsibility to give truthful testimony under oath or to make truthful statements and provide information to a government agency; (b) prohibit the Executive from filing a charge or complaint with, making a report to, participating in any investigation or proceeding conducted by, or otherwise cooperating with a government agency; or (c) limit or restrict the Executive from exercising any legally protected whistleblower rights (including pursuant to Rule 21F under the Securities Exchange Act of 1934, as amended, or any successor provision).

**ARTICLE IV**

**<u>TREATMENT OF EQUITY AWARDS UPON A CHANGE OF CONTROL</u>**

If the Executive is employed by the Employer immediately prior to a Change of Control, and either (a) the purchaser, successor or surviving corporation (or parent thereof) (the "<u>Survivor</u>") fails to either assume all of the Executive's outstanding equity awards without change, or fails to issue replacement awards with the same economic value and with similar terms and conditions; or (b) the Company or Survivor terminates the Executive's equity awards in connection with the Change of Control, then the Executive's equity awards will vest upon the Change of Control as follows:

D. Herberg Service Agreement January 2026

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Each award that vests on the basis of continued employment (without regard to the attainment of any performance goals) shall vest in full; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Each award that pays out on the basis of the achievement of performance goals shall vest in full upon the Change of Control, with the payout amount determined by the Committee in its sole discretion. In making such determination, the Committee must take into account the extent to which the performance goals have already been achieved, or, if applicable, the trend at which the performance goals are being achieved.

All payments of cash and issuance of equity required hereunder shall be made as soon as practicable after, but in no event more than ninety (90) days following, the date of the Change of Control.

**ARTICLE V<br><u>MISCELLANEOUS</u>**

**Section 5.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Survival</u>.** The obligations contained in Article Ill shall survive the expiration of this Agreement and shall be fully enforceable thereafter. In addition, the expiration of this Agreement will not affect the rights or obligations of the parties hereunder arising out of, or relating to, circumstances occurring prior to the expiration of this Agreement, which rights and obligations will survive the expiration of this Agreement.

**Section 5.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Nonalienation of Benefits</u>.** None of the payments, benefits or rights of the Executive shall be subject to any claim of any creditor of the Executive, and the Executive shall not have the right to alienate, anticipate, commute, pledge, encumber or assign any of the benefits or payments that he or she may expect to receive, contingently or otherwise, under this Agreement.

**Section 5.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>.** All notices and other communications required hereunder shall be in writing and shall be delivered personally or by registered mail or overnight express courier service (a) in the case of the Executive, addressed to him or her at the home address which he or she most recently communicated to the Company Group in writing; and (b) in the case of the Company, Adient US LLC, the Company Group or the Employer to the attention of the Executive Vice President, Chief Legal and Human Resources Officer of the Company at 49200 Halyard Drive, Plymouth, Ml 48170, with a copy to the Chairperson of the HCCC, sent to the same address.

**Section 5.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Contents of Agreement; Amendment</u>.** This Agreement sets forth the entire understanding between the parties hereto with respect to the severance benefits and supersedes any prior or other agreement or understanding between the parties with respect to such subject matter, including specifically any severance policy maintained by the Employer.

This Agreement may not be amended or modified at any time except by written instrument executed by the Company, Adient US LLC and the Executive.

**Section 5.05&nbsp;&nbsp;&nbsp;&nbsp;<u>No Contract of Employment</u>.** This Agreement shall not be construed as giving the Executive the right to be retained in the service of the Employer, and the Executive shall remain subject to discharge to the same extent as if this Agreement had never been executed.

**Section 5.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability of Provisions</u>.** Except as set forth in Section 3.07, if any provision of this Agreement shall be held invalid or unenforceable by a court of competent jurisdiction, such invalidity or unenforceability shall not affect any other provisions hereof, and this Agreement shall be

D. Herberg Service Agreement January 2026

------

deemed amended to the minimum extent necessary to permi![image_1.jpg](image_1.jpg)![image_2.jpg](image_2.jpg)t such provision to be valid and enforceable, or if such deemed amendment is prohibited by law, then construed and enforced as if such provisions had not been included.

**Section 5.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings and Captions</u>.** The headings and captions herein are provided for reference and convenience only, shall not be considered part of this Agreement, and shall not be employed in the construction of this Agreement.

**Section 5.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Controlling Law; Venue</u>.** This Agreement shall be construed and enforced according to the internal laws of the State of Michigan, without reference to the choice of law provisions thereof. The Executive irrevocably and unconditionally (a) agrees that any suit, action or other legal proceeding arising under this Agreement, including without limitation, any action commenced by any member of the Company Group for preliminary and permanent injunctive relief or other equitable relief under Article Ill, may be brought in the United States District Court for the Eastern District of Michigan, or if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Michigan; (b) consents to be subject to the non-exclusive personal jurisdiction of any such court in any such suit, action or proceeding; and (c) waives any objection which the Executive may have to the laying of venue of any such suit, action or proceeding in any such court. Adient US LLC is a Michigan limited liability company and the Company's corporate headquarters are located in Plymouth, Michigan.

**IN WITNESS WHEREOF,** the parties have executed this Agreement as of the day and year first above written.

---

| |
|:---|
| **ADIENT PLC** |
| <br>By: <u>/s/ Heather M. Tiltmann&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
| Name: Heather M. Tiltmann |
| Title: Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary |
| **ADIENT US LLC** |
| <br>By: <u>/s/ Heather M. Tiltmann&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
| Name: Heather M. Tiltmann |

---

D. Herberg Service Agreement January 2026

------

---

| |
|:---|
| Title: Manager |
| **EXECUTIVE** |
| <br>By: <u>/s/ David J. Herberg&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
| Name: David J. Herberg |

---

D. Herberg Service Agreement January 2026

## Exhibit 31.1

---

| |
|:---|
| **Exhibit 31.1** |
| **Certification** |

---

I, Jerome J. Dorlack, certify that:

1 I have reviewed this quarterly report on Form 10-Q of Adient plc;

---

| | |
|:---|:---|
| 2 | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |

---

---

| | |
|:---|:---|
| 3 | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report; |

---

---

| | |
|:---|:---|
| 4 | The Registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have: |

---

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

---

| | |
|:---|:---|
| 5 | The Registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions): |

---

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize, and report financial information; and

 (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 4, 2026 |  |  |
|  |  | By: | /s/ Jerome J. Dorlack |
|  |  |  | Jerome J. Dorlack |
|  |  |  | President and Chief Executive Officer |

---

## Exhibit 31.2

---

| |
|:---|
| **Exhibit 31.2** |
| **Certification** |

---

I, Mark A. Oswald, certify that:

1 I have reviewed this quarterly report on Form 10-Q of Adient plc;

---

| | |
|:---|:---|
| 2 | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |

---

---

| | |
|:---|:---|
| 3 | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report; |

---

---

| | |
|:---|:---|
| 4 | The Registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have: |

---

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

---

| | |
|:---|:---|
| 5 | The Registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions): |

---

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize, and report financial information; and

 (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 4, 2026 |  |  |
|  |  | By: | /s/ Mark A. Oswald |
|  |  |  | Mark A. Oswald |
|  |  |  | Executive Vice President and Chief Financial Officer |

---

## Exhibit 32.1

---

| |
|:---|
| **Exhibit 32.1** |
| **CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**  |
| **PURSUANT TO**  |
| **18 U.S.C. SECTION 1350,**  |
| **AS ADOPTED PURSUANT TO**  |
| **SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**  |

---

I, Jerome J. Dorlack, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Adient plc on Form 10-Q for the period ended December 31, 2025 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Adient plc.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 4, 2026 |  |  |
|  |  | By: | /s/ Jerome J. Dorlack |
|  |  |  | Jerome J. Dorlack |
|  |  |  | President and Chief Executive Officer |

---

I, Mark A. Oswald, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Adient plc on Form 10-Q for the period ended December 31, 2025 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Adient plc.

---

| | | | |
|:---|:---|:---|:---|
| Date: | February 4, 2026 |  |  |
|  |  | By: | /s/ Mark A. Oswald |
|  |  |  | Mark A. Oswald |
|  |  |  | Executive Vice President and Chief Financial Officer |

---

A signed original of this written statement required by Section 906 has been provided to Adient plc and will be retained by Adient plc and furnished to the Securities and Exchange Commission or its staff upon request.

<br>